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A STUDY OF THE, POSSIBLE PREVENTIVE EFFECTS OF MUSCULAR EXERCISES 
AND INTERMITTENT VENOUS OCCLUSION ON THE CARDIOVASCULAR 
DECONDITIONING OBSERVED AFTER 10 DAYS BED RECUMBENCY 
EXPERIMENTAL DESIGN 
ABSTRACT 
Studies conducted under contract with the Manned Spacecraft Center of 
NASA at the Immobilization Study Unit of the Texas Institute for Rehabilitation and 
Research in 1963 confirmed a syndrome called cardiovascular deconditioning arising 
from prolonged bed recumbency, muscular inactivity or immobilization. At the re- 
quest of the Space Medicine Branch of NASA Manned Spacecraft Center another study 
was carried out in the summer of 1964 to evaluate intermittent venous occlusion and 
muscular exercises as possible means of preventing the cardiovascular deconditioning 
observed after bed recumbency. This report describes the subjects, the planning and 
conditions of the experiment and the methods and techniques that were used. 
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FOREWORD 
The present study was sponsored by the NASA Manned Spacecraft 
Center under extension of Contract NAS 9-1461 D Dr. Lawrence F. Dietlein, 
Chief, Space Medicine Branch, served as monitor. 
The study was conducted at the Immobilization Study Unit of the 
Texas Institute for Rehabilitation and Research during the summer of 1964. A 
previous study was conducted in the summer of 1963 to document the physi- 
ological effects of prolonged bed recumbency. To the extent that this is possible, 
the bed recumbency experiments were conducted to simulate the condition of 
weightlessness. 
The purpose of the study was to investigate two possible means 
of preventing post recumbency cardiovascular deconditioning: intermittent venous 
occlusion of the lower extremities and muscular exercises with limited movement. 
This first report deals with the experimental design. Others describing the re- 
sults will follow. This is the experimental protocol as it was planned at the be- 
ginning of the study. Some variations that were introduced as the investigation 
progressed will beemphasized in the reports summarizing the results. 
The authors of this report have the following offiliations with 
Baylor University College of Medicine: Dr. David Cardus, Departments of 
Physiology and Rehabilitation; Dr. Willis C. Beasley, Departments of Rehabil- 
itation and Physical Medicine, and Dr. Fred B. Vogt, Deportment of Rehabilitation. 
The authors wish to acknowledge the help and advice of Dr. William 
A. Spencer in the organization of the study, the collaboration of Dr. Marcus 
Fuhrer in the planning and execution of the psychological studies, the cooperation 
of the Crew Systems Division, Space Medicine Branch, Bioinstrumentation 
Section, and Data Systems Development Branch of the NASA Monned Spacecraft 
Center, and the secretarial assistance of Mrs. Jacqueline Clark and Mrs. Mary 
Garber in preparing this report. 
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A STUDY OF THE POSSIBLE PREVENTIVE EFFECTS OF MUSCULAR EXERCISES 
AND INTERMITTENT VENOUS OCCLUSION ON THE CARDIOVASCULAR 
DECONDITIONING OBSERVED AFTER 10 DAYS BED RECUMBENCY 
EXPERIMENTAL DESIGN 
SUMMARY 
A study was conducted under contract with the Manned Spacecraft Center 
at the Immobilization Study Unit of the Texas Institute for Rehabilitation and Re- 
search, to evaluate intermittent venous occlusion and muscular exercise as possible 
preventive measures of the cardiovascular deconditioning observed after prolonged 
bed recumbency. This report describes the experimental subjects participating in 
the study, the planning and conditions of the experiments, the methods and tech- 
niaues of physiological and psychological testing, and the general procedure of data 
hand1 ing. 
INTRODUCTION 
The results obtained during the summer of 1963 under Contract NAS-9-1461 
confirmed that after three and fourteen days recumbency in bed the human body under- 
goes cardiovascular deconditioning. This cardiovascular deconditioning is manifested 
by increased intolerance to the tilt test and by an increase in the heart rate at rest and 
during exercise. Since manifestations of orthostatic cardiovascular instability were 
observed in astronauts Schirra and Cooper and in Russian cosmonauts after orbital space 
flights, studies on preventive measures of orthostatic cardiovascular deconditioning 
were considered of interest because of their possible effectiveness in counteracting 
cardiovascular deconditioning. At the request of NASA officials, a new series of bed- 
rest experiments was planned by Texas Institute for Rehabilitation and Research inves- 
tigators. The study was carried out in support of a Gemini inflight experiment ( pro- 
posed by NASA. officials ) aimed at preventing cardiovascular deconditioning during or 
consecutive to space flights. 
PURPOSE 
The purpose of the investigation carried out at the Texas Institute for 
Rehabilitation and Research in the summer of 1964 was to study the efficacity of exer- 
cise and/or intermittent leg cuff inflation in preventing cardiovascular deconditioning. 
The leg cuff inflation was provided in an attempt to stimulate and maintain the veno- 
motor tone as well as to prevent abnormal transfer of fluids in the tissue spaces of the 
lower extremities. The exercises were designed to maintain muscular activity during 
the time that the recumbent position was maintained. 
GENERAL CONSIDERATIONS ON THE EXPERIMENTAL DESIGN 
The principal investigators at the Texas Institute for Rehabilitation and 
Research gave careful consideration to the NASA contract extension, Amendment 
No. 2, and defined the formal statistical and analytical requirements that would 
yield a definitive evaluation of the various treatments proposed. Briefly, the fol- 
lowing statements summarize these requirements: 
The treatments would be limited to the following: 
a. Bed recumbency without exercise or intermittent inflation of 
cuffs placed on the extremities. 
b. Bed recumbency with concomitant exercise. 
C. Bed recumbency with intermittent inflation of extremity cuffs. 
The time sequence for the test periods would be two weeks for each 
treatment (b) and (c); there would be a following treatment (a), which would occur 
twice in the sequence. Th is would give effectively four treatment periods of two 
weeks each, with interposed stabilization periods of equal duration. 
Taking these four treatment periods as the basis for the experimental 
design, the neutralization of the effects from time order would require 24 permutations 
of the sequence. The time interval between treatments would still be another factor, 
which in a totolly effective design should be varied to gain knowledge as to the 
minimum value required for recovery to the initial conditions. For the present design, 
this period was assigned a fixed value of two weeks. 
Each permuted group should contain a sufficient number of individuals 
to permit a reliable estimate, which is generally recognized as 30 subjects, to 
achieve a valid estimate relative to biological variation among individuals. For 24 
permutations, a minimum of 720 subjects would be required. This complete permutation 
3 
. 
of four treatment periods would involve one complete replication of the total ex- 
periment, since the treatment (a) bed recumbency alone, although duplicated in each 
period of four treatments, would present a replication when permuted. This meant that 
there would be exactly twelve different sequences presented in the complete permutation, 
and each of these would be repeated once in the set of twenty-four. The power of the 
statistical analysis would be doubled by this replication, which would permit an estimate 
of reliability for the total experiment. This might seem to be excessive, but years of 
experimental science in studies involving biological variability stands as o witness to the 
correctness of this approach. Such sampling waJd permit a reliable estimation of in- 
teraction effects between variables in a multiple frame that could not be achieved 
otherwise. This design was not impossible, but was expensive. It would, however, 
produce definitive answers to the problems posed. 
As a compromise dictated by the proposed budget and the specified time 
for execution of the actual experimentation, one sequence was chosen of the possible 
12 different permutations. We did not know whether the stabilization period of two 
weeks was odequate for each individual to return to his initial condition (prior to the 
beginning of the preceding treatment period ). In the sequence chosen, there was also 
a lack of a full two weeks pre-sequence observation period because of the unavailability 
of subjects who were to be medical and dental students undergoing end-of-year exom- 
inations. 
We chose as a criterion of recovery to the initial condition uniformity of 
response to the following tests: (a) lack of orthostatism on passive tilt (b) bicycle ergom- 
etry, and (c) response to isometric exercise. These criterion tests were scheduled at the 
beginning and end of each treatment period. The permutation chosen might provide 
r 
indicative trends on the effects these treatments depending on the uniformity of response 
among the subjects in the small sample of six. Such a minimal experiment would not 
yield statistically valid conclusions on the multiple interaction effects. 
PLAN 
The calendar of experimentation for the studies conducted in the summer 
of 1964 is shown in Figure 1 . Three IO-day bed recumbency periods are indicated. 
During recumbency period number 1, half of the subjects had cuffs applied to their 
lower extremities, and the other half of the subjects performed a routine of periodic 
“isotonic” exercises. During recumbency period number 2, the subjects who pre- 
viously had cuffs performed exercises, ond the group who had performed exercises had 
cuffs applied to their lower extremities. During recumbency period number 3, all of 
I 
the 10 subjects were exposed only to the IO-day period of Bedrest. 
The cuffs were applied to the proximal port of lower extremities and 
were inflated to a pressure of 75 mm Hg with a cycle of 5 minutes on, 10 minutes off, 
for the entire duration of the lo-day period preceding the first period of recumbency. 
A 3-week intervol was allowed between bedrest periods to assure that the subjects had 
recovered from the deconditioning that occurred with each period of recumbency. The 
subjects were submitted to bedrest in 2 groups separated by one day to allow for per- 
formance of a complete tilt-toble test on the day immediately preceding bed recumbency, 
OS well as on the final day of bed recumbency. Numerous other testing procedures 
were carried out on the subjects periodically and are indicated in the Appendix. 
SELECTlION AND DESCRIPTION OF SUBJECTS 
The subjects were selected from the local college population on the basis 
of oge, current health, and past medical history. Their ages ranged from 21 to 25 years. 
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Figure 1 
Fees of 10 dollars per day during routine testing and recovery periods, and 30 dollars per 
day during the bed recumbency period were paid to the subiects. Each potential subject 
was given a complete medical history ( see Appendix 1 ), and physical examination ( see 
Appendix 2 ) by a physician. The physical exam included a routine chest x-ray, serology, 
CBC, urinalysis, and electrocardiogram. The response to a simple tilt-table test ( 20 
minutes duration ) determined the selection of a prospective subject. The subjects were 
admitted to the Texas Institute for Rehabilitation and Research as hospital patients for 
experimental studies. They signed the proper forms and authorizations relinquishing 
responsibility prior to active participation in the study. The purpose of the experiment 
and the risk involved were explained to them in detail prior to the start of the study. In 
addition, each individual selected for the study was submitted to a psychological in- 
terview which included Cattell’s 16 PF, Guilford’s Activity Dimension, and the Focused 
Thematic Apperception test ( see Appendices 11.1.1, 11.3 and 11.4 ). 
Psychometric assessment revealed no notable psychopathology within the 
subject-group. As indicated by the Cattell personality inventory, the subiect’s pro- 
files did not deviate substantially from average profiles obtained in a normative popu- 
lation of college males. It is perhaps noteworthy that the mean score for the group on 
the anxiety factor was shifted in the direction of high anxiety. This may have reflected 
the subjects’ uncertainty and concern about the impending events in the study. 
It was particularly interesting to examine the scores of the one subject 
who had to be replaced after the first ten days of bedrest. At least two of this subject’s 
scores might have justified the prediction that he would have difficulty in adjusting 
to the stresses inherent in the experimental situation. First, he received the highest 
anxiety score of any subiect. Second, this subject’s score for mental adjustment, 
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though not extremely deviant from the scores of the normative population, was the lowest 
within the subject-group. 
Eleven healthy adult males were utilized as experimental subiects. They 
were coded for identification for scheduling ( see Appendix 3 ). Nine of the subjects 
participated in all 3 periods of recumbency; Subject A.P. K. participated only in 
the first period of recumbency and was replaced by Subject L. F. E. who participated 
in the last 2 periods. 
The subjects’ physical characteristics are shown in Table 1. The detailed 
somatic descriptions of the subjects are recorded in the Texas lnstitlfe for Rehabilitation 
and Research clinical histories, the identification number of which is indicated in the 
second column of Table 1. These histories are kept in the Medical Record Room of the 
Texas Institute for Rehabilitation and Research. Photographs showing the body build 
of these subjects are presented in Figure 2. 
DESCRIPTION OF TESTING AREA 
For the entire duration of the experimental study the subjects were housed 
in an experimental ward located in the basement of the Texas Institute for Rehabilita- 
tion and Research. Figure 3 shows a view taken from one end of the ward. Privacy for 
individuals beds was provided by means of a curtain which circled each bed. Environ- 
mental conditions were controlled by the usual hospital environmental control mechan- 
isms. The temperature and humidity were maintained fairly constant at 74’F. and 58%, 
respectively, throughout the studies. Barometric pressure was not controlled. There 
were no measurements made of these conditions on a routine basis. The area was ful I y 
air-conditioned. The I ights were turned off every night at 10:00 p.m. and turned on 
at 7:00 a.m. There was a television set in the room which was turned off every night 
at 11:OO p.m. 
TABLE # 1 
1 
1 T T T 
L 
T T T T T T I 1 
A 
A 
Nk 
- 
NC 
1 
NC 
NP 
70020 
70028 
70021 
70022 
70019 
70018 
70023 
70024 
70025 
70026 
70027 
T 
, 
B 
T t 
- 
177.8 65.2 71.2 1.88 
190.5 75.9 81 .6 I 2.10 
173.4 65.6 67.1 1.80 
179.1 83.1 72.1 l.!Xl 
177.8 70.2 71.2 1.88 
163.2 51.7 56.2 1 .60 
174.0 60.4 68.0 I 1.82 
170.8 67.2 65.3 1.76 
Age is determined from the last birthday unless a birthday occurred during the study. 
Theoretical weight is determined by height plus 1 inch (for shoes) minus 7 pounds 
(for men’s c,lothes). The chart is a Metropolitan Life Ins. Co. height-weight chart. 
Theoretical Body Surface Area (BSA) is determined by the Dubois Body Surface 
Chart (as prepared by Boothby ond Sandiford of the Mayo clinic). 
Classification: A=othlete; NAcnon-athIete. 
The height given was determined at the beginning of the study. 
The weight given was determined at the beginning of the study. 
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CONTROL OF SUBJECTS 
A. During Bed Recumbency 
The subjects were required to remain in bed during the recumbency 
periods. They were given one pillow for use under their head, were allowed to turn 
in bed and roll from side to side, and to feed themselves by turning on their side in 
bed. They were not allowed to sit in bed or to get up for bathroom privileges. Sub- 
jects were supervised by a physician during the bed recumbency periods, and a phy- 
sician was on call during all other times of the study. Two orderlies assisted in sub- 
ject care-one during the day, and the other during the night. 
B. Before and After Bed Recumbency 
During the pre-bed recumbency and recovery periods, the subjects were 
encouraged to follow a routine approximating that prior to becoming an experimental 
subject. The subjects spent every night in the ward, including the nights of the re- 
covery periods. Athletes were al lowed to participate in an active training schedule 
if they had followed one previously. Except for the times of testing, eating and urine 
collection periods, the subjects were free to come and go from the hospital. The re- 
cord of activities performed was kept on an hourly basis according to a daily activity 
record (see Appendix 4). 
C. Meals 
The subjects were given a standard hospital kitchen diet and were required 
to eat all food that was served to them. The food trays were prepared and weighed 
to provide each subject with an identical diet. The dietary content of sodium chloride 
approximated 10 grams daily. An additional food tray was prepared and sent to the 
laboratory for analysis of sodium and potassium content. No food or beverages were 
allowed during the times the subjects were away from the hospital. The subjects 
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Figure 3. View of Experimental Ward 
were allowed to drink distilled water ad Iibitum, but a strict record for intake was 
maintained (see Appendix 5). 
PHYSIOLOGICAL AND PSYCHOLOGICAL OBSERVATIONS 
A. During Bed Recumbency 
1. 
2. 
3. 
4. 
5. 
6. 
Periodic serum sodium and potassium determinations were made using the flame 
photometry technique. 
Urine was collected in 6-hour collection periods which began at 1 a.m. over 
the entire duration of the study. Sodium, potassium and osmolarity deter- 
minations were made on each 6-hour sample for each subiect, using the flame 
photometry technique. A total 24-hour aliquot was also obtained and analyzed 
for sodium and potassium. Urine was collected and preserved for the deter- 
mination of 17-hydroxycorticoids and catecholamines on the same 6-hour 
samples (see Appendix 6.1 and 6.2). 
Food was pooled for a 24-hour period and analyzed for sadium and potassium 
content using the flame photometry technique. 
Feces was pooled for a 4 to 6 day collection period depending on the phase of 
the study and was analyzed for sodium and potassium content using the flame 
photometry technique (see Appendix 7). 
Radioisotope measurements to determine plasma volume, extracellular fluid 
space, total body water, and red cell mass were determined on days 1, 4, and 
10 of each bedrest period (see Appendix 8). 
Body Weight: Each subject was weighed daily in the early morning after empty- 
ing his bladder. During the periods of bedrest, weights were obtained by means 
of a platform scale rolled to each bedside so that the subjects could maintain a 
horizontal position (see Appendix 9). 
16 
7. Leg Circumference: Measurements of leg circumference at three sites on each 
leg were made twice daily, in the morning and the afternoon. These measure- 
ments were performed using a flexible measuring tape which was wrapped a- 
round previously determined marks on the legs to assure that the same sites 
were measured at all times (see Appendix 10). 
8. Psychological Testing: A test battery consisting of: (a) simple reaction time, 
(b) aiming, (c) visualization, (d) number facility, and (e) speed of closure was 
administered immediately preceding and following each passive tilt procedure 
and on the fourth day of bed recumbency. The Holtzman Inkblot Test and an 
alternating perspective measure were administered on days 2, 6, and 10 of bed 
recumbency. Tests of time perception, word fluency, perceptual speed, and 
responses to the Clyde Mood Scale were obtained twice daily. At the conclusion 
of each period, responses to a questionnaire were obtained from the subjects. In 
addition, ranking of the subjects was obtained from independent observers along 
four dimensions: (a) sociability, (b) arousal, (c) attitude toward the experiment, 
and (d) affective expression. Additional variables were administered during the 
second and third bed recumbency periods. These included reaction time, number 
facility, speed of closure, visualization and aiming (see Appendices 11.1.3, 
11.3, and 11.4). The details of the psychological studies will be given in a 
separate report. 
B. During Provocative Testing 
After each bed recumbency period the subjects were tested with passive tilt, 
the bicycle ergometer, and Erkin exercise. A brief description of these provocative 
tests follows: 
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1. Passive Tilt Test 
Comprehensive head-up passive tilt procedures were conducted on the sub- 
jects immediately before and after the 3 periods of recumbency. In addition, 
simple tilt procedures were determined weekly during the pre-bed recumbency 
period and during the recovery periods to determine the individual’s day-to- 
day pattern of response to the tilt-table test (see Appendix 12.1). 
The procedure used in performance of comprehensive head-up tilts was as 
follows: 
a. The subjects were given nothing by mouth for several hours prior to the 
tilt-table test to protect against regurgitation and aspiration of foods 
should fainting and an association vagal response occur. It was found 
desirable to allow the subjects to drink a glass of milk several hours be- 
fore the tilt procedure so that they would not be hungry at the time the 
tilt-table test was performed. 
b. The subject was fitted with appropriate sensors prior to being placed on 
the tilt-table. 
c. An emergency cardiac drug tray, defibrillators, cardiac pacemaker, 
artificial respiration equipment, and atropine drawn into a syringe was 
kept available for any cardiac emergency, 
d. A motorized tilt-table with an English saddle type of support was used to 
tilt the subjects from 0 to 70° in 30 seconds. Provision was made to release 
the gear mechanism for instaneous tilt-down with occurrence of syncopal 
or vagal type of reactions. 
e. Measurements during the tilt-table test included the following: 
1) Frank Lead system vectorcardiogram. 
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2) Impedance pneumogram. 
3) Intra-arterial blood pressure from the right brachial artery. 
4) Forearm circumference changes by means of a Whitney mercury-in- 
rubber strain gauge connected to a Sanborn amplifier. 
5) Right and left leg calf circumference by a Whitney mercury-in-rubber 
strain gauge placed around the calfs of both legs at the same site for 
each tilt procedure. 
6) Precordial vibration by means of Ling-Temco-Vought capacitance type 
of microphone. 
7) Venous pressure from the left forearm by means of venous introcatheter 
connected to a Statham pressure tranducer. 
8) Measurements of forearm blood flow, venomotor tone, and peripheral 
vascular resistance were determined (see Appendix 12.2). 
f. Pulmonary ventilation measurements made by means of arterial blood 
samples and expired air samples simultaneously obtained during a two- 
minute period from each subject prior to tilting. 
g. A Flack procedure performed 5 minutes prior to and 5 minutes after tilt- 
ing the subject to the 70’ upright position. A code sheet was used for tilt- 
table studies to record observations made during the study, and to document 
the time of occurrence of the various tests performed. Each sheet allows 
for identification of the magnetic tape, test date, subject number, time 
of day, experimental circumstance, and the EECO code corresponding to 
the magnetic tape (see Appendices 12.3 and 15.1). 
The simple tilt differed from the comprehensive tilt study in that only one 
lead of ECG was obtained and blood pressure was obtained by a cuff-microphone 
technique rather than by direct arterial puncture. 
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The details of the tilt studies will begiven in a separate paper. 
2. Bicycle Ergometer Test 
Bicycle ergometer tests were conducted on the subjects of this study before 
and after the recumbency periods ( see Appendix 13.1 ). The Lanooy Bicycle 
Ergometer was used for these studies. 
The information recorded before, during and after bicycle testing consisted 
of: 
1) Frequency of the heart 
2) Frequency of breathing 
3) Pulmonary ventilation 
4) Oxygen consumption 
5) CO2 elimination 
6) Heart rate recovery time 
Pulmonary ventilation, oxygen consumption, and CO2 elimination were ob- 
trained from samples of expired air obtained at 40, 80, 120 watts, and at the final 
work load. The concentration of oxygen and CO2 in the samples of expired air 
were carried out with the Scholander apparatus. Volumes of expired air were mea- 
sured with a wet gas meter. This information was recorded in source documents 
( see Appendix 15.2.1 through 15.2.5 ) for automatic data processing. 
The electrocardiogram and the impedance pneumogram were continuously 
recorded on magnetic tape. Th is information was coded in source documents 
(see Appendix 15.2.6 through 15.2.8). Th e information stored on magnetic tape 
was played back with a strip chart recorder for pre-automatic processing inspection. 
It was further digitized by means of automatic analog to digital conversion. 
Figure 11 is a photograph of the exercise laboratory with the instrumenta- 
tion layout. The details of the results of the bicycle ergometer test including 
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Figure 11. View of the Exercise Laboratory and Instrument Layout 
gas exchange analysis and heart rate response will be given in separate reports. 
3. Erkin Tests and Exercises 
The Erkin* program is divided into two aspects: (1) criterion test (Erkin I, 
I I, Ill, IV, and VI) designed to evaluate strength level, endurance, and 
cardiovascular response to this form of stress tests; and (2) conditioning exercises 
(Erkin V) intended to aid in the prevention of physiological deconditioning ob- 
served after bed recumbency. The schedule of the various Erkin tests and 
exercises is given in Appendix 14.1. 
The objectives of the bedrest studies were reviewed in detail prior to de- 
vising these Erkin tests and exercises. Restrictions upon the form of the proposed 
exercise resulted from the limitation in the range of motion of the arms (elbow 
flexion) and the short range of extension allowable at the knee joint. The 
exercise procedure was designed so that it could be used by astronauts in the 
Gemini space capsule. The conditioning exercises were developed, therefore, 
around a pattern of isotonic motion of limited range. 
The device employed for conditioning exercises is called a Bungie since 
the load is produced by the stretch imposed upon two strands of bungie rubber, 
such as that used in underwater spear guns. An initial model of this exerciser 
was provided by NASA. Subsequently, several modifications were made to adapt 
the primary model more effectively to this study program. 
In order to have predictable and measured loads or exercise doses for each 
individuai subject, the bungie strands were carefully calibrated by applying 
known weight loads and measuring the stretch produced. Calibration curves 
* The term “Erkin” was improvised from the words ergonomics and Kinesiology as a brief 
designation for this program. It is used also as a coding category for computer processing 
of data (see Appendix 15.3). 
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were derived from these data for all bungie strands employed in the exercisers. 
Also, several strands were hazed up to 5000 times to determine durability and re- 
tention of elasticity. The exercise units were then assembled in a manner to per- 
mit adjustments in load and range for individual subiects. 
Erkin III was designed as a functional test and is described below, along 
with Erkin V which was designed as a conditioning exercise. 
The Erkin III test was designed to reveal the subiect’s condition and changes 
from time to time in respect to strength level, endurance (or fatiguability), and 
response of heart rate to 50 per cent of maximum exercise series. The sequence 
was standardized for each subject. This test was given before and after each 
bedrest period and several times between. It was used throughout the whole study 
as a criterion of changes in the mentioned particular functions. This test was 
also given to each subject on the last day of each bedrest period (the day preced- 
ing tilts) with the standing phase omitted. The following is the standard sequence 
employed in Erkin III while tensive force of each pull, the electrocardiogram, 
respiration and blood pressure were monitored: 
a. Subject stands one minute. 
b. Subject lies supine, and gives two maximum pulls on the tensiometer 
cable, arms at full extension. 
c. Subject rests quietly four minutes. 
d. Subjects pulls fifteen times, five seconds on, five seconds rest on cable 
tensionmeter at maximum effort. 
e. Subject rests quietly five minutes. 
f. Subject pulls fifteen times, five seconds on, five seconds rest, on 
cable tensiometer at maximum effort. 
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9. Subject rests quietly five minutes. 
h. Subject stands one minute. 
The Erkin V conditioning exercise was the standard in-bed exercise routine 
used throughout the study for individuals (or groups) for whom exercise was pre- 
scribed. The dose used for each individual was that standarized in the Erkin II 
series, and remained the same throughout. Each subject had his own Bungie 
exerciser. 
These exercises were performed simultaneously by all subjects for whom 
exercise was prescribed in the master protocol. The routine was repeated ten 
times daily, at hourly intervals throughout the ten-day bedrest period, be- 
ginning at approximately 8:00 a.m. 
The exercise routine was as follows: 120 pulls on the prescribed Bungie 
at the rate of one pull per second, i.e., an exercise period of two minutes. 
This routine was interrupted slightly once per day during the bedrest period 
for ECG monitoring. The routine was also monitored with ECG twice before 
and twice after each bedrest period. For this set, each individual was tested 
sequentially, and the ECG was monitored two minutes before the exercise. 
This monitoring once daily was done also to subjects not on the exercise schedule. 
During the control bedrest period when no subjects were on exercise, Erkin V 
was given once every two days to all subjects as a criterion test. 
A brief summary follows of the purpose and the procedure for each of the 
other Erkin tests as used throughout this study (see Appendix 14.2). 
The details of the Erkin exercise and testing program and the analysis of 
Erkin Ill Criterion Testswill be discussed in a separate report. 
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INSTRUMENTATION 
The general instrumentation developed for this study will be described 
in a separate report. Specific instrumentation for Erkin exercises and testing, tilt 
testing, and bicycle ergometer testing will be described in the reports giving the 
results obtained with each of these testing procedures. 
DATA PROCESSING 
Laboratory data and analog recordings of the functional tests were 
prepared for automatic data processing. A considerable amount of data was 
manually digitized for preliminary reports and presentations of the data. In some 
instances, semi-automatic devices for analog-to-digital conversion were used for 
the same purpose. 
A technique was studied for the automatic analog-to-digital con- 
version of the electrocardiogram and blood pressure recordings obtained during 
the bicycle ergometer test, the tilting procedure and the Erkin tests. 
All the discrete data was punched into cards for electronic data pro- 
cessing (see Appendix 15). The data were conveniently prepared for statistical 
analysis. The general statistical methods and automatic data processing techniques utilized 
will be described in a separate report. 
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REVIEW OF PROGRESS 
In accordance with Amendment 3 of the contract, brief monthly progress 
reports were made to Dr. Lawrence F. Dietlein, Technical Monitor of the project, and 
to Mr. A. C. Wilder, Contracting Officer. 
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Appendix 1 
SUBJECT CANDIDATE QUESTIONNAIRE* 
TEXAS INSTITUTE FOR REHABILITATION AND RESEARCH 
in the 
Texas Medical Center 
IDENTIFICATION DATA 
Subject Number: (not to be filled out by applicant) I I I I I 1 
Name: _. ~~ 
Last name first) 
Dote of Birth: 
Religion: 
1 I I I I I 1 
MO. Day Yr. 
Place of Birth: 
(City and State) 
(Please use proper code numbers in answering questions) 
Sex: (1. Male, 2. Female) I I 
Race: (1. White, 2. Negro, 3. Latin American, 4. Yellow, 5. Other) (-1 
Current Height: (in inches) I ! I 1 
Usual Weight (in pounds) [ I I I 
Marital Status: (1. Single, 2. Married, 3. Divorced, 4. Widower) 1-1 
Current Occupation: (1. Student, 2. Employed, 3. Unemployed, 4. Other) 1-1 
If employed: 1. Current Occupation: 
2. Employer: 
If student: 1. What is major course? 
2. Where attending? 
3. Working toward what degree? 
4. Have you ever been on scholastic probation? 
5. Have you ever been expelled from school? 
If yes, give cause: 
* This questionnaire was adapted from the 1963Study. 
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Appendix 1 (cont’d) 
EDUCATION AND WORK EXPERIENCE 
List below names of schools (begin with High School) you have attended. 
Dates 
From To Name Location 
Degree 
Obtained 
I II I I 
List below in chronological order any jobs you have held in the past 
and the length of your employment. 
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Appendix 1 (cont’d) 
PAST MEDICAL HISTORY 
DEVELOPMENTAL HISTORY 
(Please use proper cod= in answering questions) 
To the following questions answer: 1. Don’t know, 2. No. 3. Yes 
Were you o full term bob 
Were you a premature b 
Did you have any abnor 
Were you breast fed 
Were you bottle fed 
As a child did you have any problem with the following: 
Feeding or nursing 
Temper Tantrums 
Indicate APPROXIMATE age in months of the following: (if known). 
Sitting up 
Walking 
First Distintive Words 
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Appendix 1 (cont’d) 
ILLNESSES 
The following is a list of frequent illnesses in childhood or adulthood. 
Please indicate whether or not you have had any of them. If you do not know, 
olease indicate. 
List all other illnesses that you hove had. 
Were you hospitalized? Recovery complete ? 
Year Age Disease or Complaint If so, where? If not, complications. 
Venereal Diseases: Syphilis, Gonorrhea or other (please specify). 
Year Age Disease Were you treated? Were you given full clearance? 
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Appendix 1 bnt’d) 
Allergies: Are you at the present time allergic to any one of the following? If 
you have allergies to agents not indicated below, please list them in 
the blank spaces provided. Indicate:l.Don’t know, 2. No, 3. Yes 
Hay Fever 
hocolate 
Penicillin 
Sulfa 
Other Druas 
I 
Dust I I 
Insects 
Other: 
I 
I 
I 
OPERATIONS 
List all known operations since birth, even minor ones such as circumci- 
s ion. By as precise as possible in giving dates. 
Date Name of Where 
INJURIES OR ACCIDENTS 
List all injuries or accidents requiring the services of a physician. Be as 
precise OS possible in giving dates. 
Date 
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Appendix 1 (cont’d) 
IMMUNIZATION RECORD 
Use Code: 1. Don’t know, 2. No, 3. Yes 
1 I { 
Have you received the following immunizing agents? Use Code: 1. Don’t know, 
2. No, 3. Yes. Indicate when you last received the serum by year. 
Serum against Tetanus 
What year 
Serum against Diphtheria 
I 
What year I 
amma Globulin 
What year I 
ny other: Give type and year. 
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Appendix 1 (cont’d) 
FAMILY H ISTORY 
LIVING RELATIVES 
Paternal Grandmother 
bon 
son 
Son 
Daughter 
Daughter 
Daughter 
Daughter 
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Appendix 1 (cont’d) 
FAMILY HISTORY 
DECEASED RELATIVES 
Relation Cause of Death Age at Death 
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Appendix 1 (cont’d) 
DISEASES IN FAMILY 
Disease 
Don’t 
know No Yes Relatives affected 
MILITARY SERVICE 
If you have served in any branch of the Armed Forces, Please answer 
the following questions. 
Branch of service 
r 
Total number of months in service Classification 
If you received dishonorable discharge, give cause: 
I 
ffyou have retained reserve status, give last date of duty tour and location: 
I 
I 
I 
List<ny honors or decorations you received while in service: 
I 
t I 
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Appendix 1 (cont’d) 
SOCIAL HISTORY 
SMOKING 
Use code: 1. Don’t know, 2. No, 3. Yes, in answering the following 
questions. 
Have you ever smoked? 
Do you now smoke? 
If yes to above question: 
I I 
I 
DRINKING 
Have you ever drunk alcoholic beverages? !l 
Do you now drink alcoholic beverages? 
If you drink socially put a check mark in the box 
If you drink regularly, indicate the average number of drinks per day 
you take. 
If you drink beer regularly, indicate the average number of beers 
you drink per day. 
Please indicate your average daily consumption of the following: 
Coffey (indicate the number of cups) 
Hot tea (indicate the number of cups) 
Cold tea (indicate the number of glasses) 
Milk (indicate the ,number of glasses) 
Coke (indicate the number of bottles) 
DIET 
Describe your average breakfast: 
I 
Describe your average lunch: 
Describe your average dinner: t 
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Appendix 1 (cont’d) 
SOCIAL HISTORY 
DIET (continued) Use code: 1. Don’t know, 2. No, 3. Yes 
Have you ever dieted to lose weight? 
Have you ever taken medication to he p you lose weig to 
- 
If yes, give name of medication and dosage: 
Are you at the Gresent time taking medication for weight loss? 
I 
I t 
EXERCISE 
Give an estimate of the amount of exercise that you do in one week. 
Please use this rating. 1. Minimal amount, 2. Moderate amount, 
3. A lot. I1 
SPORTS 
Use code: 1. Don’t know, 2. No, 3. Yes 
Have you ever been engaged in active sports? 
Are you noxngaged in active sports? 
Please inxate the sports in which you 
and those in which you now participate. 
DRIVING 
Use code: 1. Don’t know, 2. No, 3. Yes 
Have you be.:n or are you now a regular operator of any of the following 
vehicles: 
Car I 
Plane 
Motorcycle 
Bus or Public vehicle 
Power boat 
Sail boat 
Other: I 
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Appendix 1 Gnt’4 
RESIDENCES 
Please list below the names of the places where you have resided. 
Give name of town only: 
Dates 
From I To i Name of town 
Have you ever lived or visited in another country? 
Use code: 1. Don’t know, 2. No, 3. Yes: 
If yes, give the name of the country and the length of your stay. 
I 
CONTAGIOUS CONTACTS 
Please indicate with check in box if you have had any recent contagious con- 
tact with any of the following illnesses. 
measles 
chicken pox 
mumps 
meningitis 
tuberculosis 
typhoid fever 
poliomyelitis 
i%J 
venereal disease 
hepatitis 
other: 
CURRENT MEDICAT IONS 
If you are currently tak i n g any medications (including aspirin) please indicate 
the following: 
IName of medicine Amount Frequency Only occasionally 
I I 
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Appendix I (cont’d) 
SYSTEMS REVIEW 
Please put a check mark ( -/ ) in box if you have or 
following, 
HEAD 
EYES 
EARS 
have had any of the 
11 Frequent headaches 
Frequent pain in face 
Pounding headaches or flushing of the face 
Migraine 
Intermittent swelling of the face not related to injury or infection 
Need to use glasses I I 
Contact lenses I 
Farsightedness I 
Nearsightedness 
Astigmatism 
1 1 
Crossing of the eyes 
BI ind spots 
Partial blindness ofyour visual field 
Difficulty in seeing at night 
Color BI indness 
Yellowish discoloration of the eyes 
Swelling of the eyelids in the mornings 
Pain in the eye 
Burning or itching of the eyes 
Pressure feeling in the eyes 
Double Vision 
Lump in the eyelid 
Injury to the eye ball 
Operation in the eye 
Intolerance to bright-&K - 
Severe earache 
Draining in ears 
Ruptured ear drum 
Temporary or permanent hearing loss 
Ringing or buzzing in the ears 
Dizziness 
Air sickness 
Motion sickness 
Mastoiditis 
Otitis media 
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Appendix 1 (cont’d) 
SYSTEMS REVIEW 
EARS (continued) 
Trouble with your ears after swimming 
Surgery to the ears 
NOSE 
Frequent head colds 
Frequent sneezing 
Excessive nasal discharge 
Frequent nose bleeding 
Post Nasal drip 
Trouble breathing through the nose 
Deviation of the septum 
Fracture of the nose 
Surgery of the nose 
Acute sinus infection 
I 
I 
I 
Chronic sinus infection 
Difficulty in smelling various odors 
Stuffy nose 
All ergic reaction to: 
Plants 
Dust 
Insects 
Other 
If yes to above, specify: 
I 
MOUTH 
Frequent sores inside of the mouth 
Fever blisters around the mouth or throat 
Frequent bleeding or tender gums 
Complete or partial dental plates 
Pyorrhea or infection of the gums 
Large number of cavities in your teeth 
Excessive bleeding following extraction of tooth 
Frequent toothache 
Intolerance to cold in contact with the teeth 
Intolerance to heat in contact with the teeth 
Dental work in the last six months 
Foul breath or halitosis 
Excessive dryness of the mouth 
Abnormality in sense of taste 
Appendix 1 (cont’d) 
SYSTEMS REVIEW 
THROAT 
SKIN 
Difficulty in pronouncing words 
Frequent soreness in throat 
Hoarseness 
Recent and permanent change in your voice 
Stuttering 
Difficulty in swaffowir 
1 
I 
I 
1 
Easy bruising 
Excessive sweating 
Ulcers on any part of your skin 
Discoloration of the skin 
Any moles 
Skin rashes 
Dryness of the skin 
Greasy coating of the skin 
Giant hives (urticaria) 
Excessive loss of hair 
Changing in the texture of the hair 
Excessive softness of the hair (seborrhea) 
NECK 
Deformities of the neck 
Enlargement of the glands ot the neck 
Tumors or masses in the neck 
Pain or stiffness in the neck 
Whiplash accident 
Wryneck 
Visible pulsating veins 
SPINE 
51 ipped disc 
Low back pain 
Back injury 
Deformity of the spine 
Fracture of the spine 
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Appendix 1 (cont’d) 
SYSTEMS REVIEW 
RESPIRATORY 
Chronic or recurrent cough 
Coughing up of blood or pus 
Pain in chest 
Shortness of breath while lying down 
Shortness of breath while sitting up 
Asthmatic attacks 
Chest wheezes 
Collapsed lung 
Shingles of the chest wall (small vesicles or herpes zoster) 
Pain in the chest on deep breathing 
Pleural inflammation 
CARDIOVASCULAR 
Disturbances in the blood supply to the heart (coronarie 
Bluish discoloration of the lips, skin, fingers or toes (cy 
Congenital defect in the heart 
Hardening of the arterie 
Loss of consciousness fro 
Chest pain during exercise 
Occasional dizzy spells 
Easy tiring with slight e 
DIGESTIVE 
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Appendix 1 (cont’d) 
SYSTEMS REVIEW 
DIGESTIVE (continued) 
Intermittent pain in the ab 
Need to get up in the morning h 
in the stomach 
Bowel distention 
Hemorrhoids 
Unusual amount of hicc 
Pain in rectum 
Pain during bowel movements 
Lack of control of the bowels 
Large, bulky, foamy or foul smelling stools -~ 
ENDOCRINE 
Fluctuations in body weight independe.nt of dieting I 1 
Excessive amount of fat in the body (obesity) 
Excessive weight loss 
Cravi ng for food 
Excessive thirst or craving for water 
Excessive amount of urinary output 
Diabetes 
Need to take insulin 
Fullness of the neck (goiter) 
Need to take thyroid medication 
Dry and scaly skin 
I 
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SYSTEMS REVIEW 
ENDOCRINE (continued) 
Coarse hair 
Protusion of the eyeballs and marked jitters 
Retention of water in the skin and swelling of some parts of body 
Excessive sweating 
Unusual amount of hair (hirsutism) 
Precocious appearance of hair on the body or around the genitalia 
Loss of calcium from the bones 
Tendency to have spontaneous fractures of the bones 
URINARY 
Difficulty in passing urine 
Need to have a catheter in bladder for any reason 
Infection of the kidneys 
Infection of the bladder 
Pus in the urine 
Blood in the urine 
Sugar in the urine 
Albumin or protein in the urine 
Dark brown urine 
Kidney stones 
Shooting pains in the back radiating down to the testicles 
Need to get up at night to pass urine 
Frequency in urimtion 
Burning sensation during urination 
Trouble starting or stopping the stream during urination 
Inability to control your bladder 
GENITALIA (to be filled out by men only) 
Circumcision 
Swelling or enlargement of either testicle 
Injury to the testicles 
Itching around the genitalia 
Urethral discharge 
Hernia 
Swel I ing of the scrotum 
Sexual difficulties 
Sterility 
Infection of the prostate gland 
Enlargement of the prostate gland 
Pain in your penis 
Injury to your penis 
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EXTREMITIES 
Numbness or tingling of the feet 
Numbness or tingling of the hands 
Pain in the calves of the legs while walking 
Shooting pains down the leg 
Swelling or enlargement of the veins in the legs (varicose veins) 
Swelling of the feet or ankles 
Swelling of the hands 
Blood clots in the legs 
Stiffness of the joints 
Dislocation of any joint 
Pain in any joint 
Swel I ing of any joint 
Injury or fractures of any joint or bones 
MUSCLES 
A feeling of weakness in some of your muscles 
Twitching of the muscles 
Loss of muscle mass (atrophy) 
Increase in the size of the muscles (hypertrophy) 
I7 I I 
I 1 
Weakness after exercise I I 
Low grip strength 
Difficulty in loosing your grip after grasping an object with the hands 
Muscle tenderness 
Inflammation of muscles 
CENTRAL NERVOUS SYSTEM 
Coma or unconsciousness 
Convulsions 
Difficulty in falling asleep (insomnia) 
Tendency to fall asleep 
Tendency to be excited 
I 
Weakness or paralysis in any muscle group 
Brisk or jerky reflexes 
Decreased reflexes 
Sustained tremors 
Decreased sensation to touch in any part of the body 
Decreased sensation to heat or cold 
Need to have a spinal tap 
Injury that has rendered you unconscious 
Encephalitis 
Meninaitis 
Electroshock treatments I I 
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SYSTEMS REVIEW 
CENTRAL NERVOUS SYSTEM (continued) 
Surgery to the brain or spinal cord 
Injury to surgery to nerve 
Difficulty in identifying objects 
Staggering gait 
GENERAL 
Have you ever had any blood transfusions reactions 
Have you ever been exposed to any of the following: 
Toxic substances (be specific) 
I X-ray radiation I 1 
Poisons (be specific) I 
Chemicals (be specific) I 
I Wther toxics: I I 
I 
REMARKS: (not to be filled in by subject candidate) 
J 
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PHYSICAL EXAMINATION SHEET 
HISTORY AND PHYSICAL 
NAME: 
DATE OF ADMISSION: 
REASON FOR ADMISSION: 
NUMBER: 
PAST HISTORY: (This included past medical, past traumatic, past surgical, etc.) 
FAMILY HISTORY: 
SOCIAL HISTORY: 
REVIEW OF SYSTEMS: (This included skin, head, neck, cardiovascular, respiratory, 
EENT, locomotor, neuropsychiatric, genito-urinary, gastro- 
intestinal) 
PHYSICAL EXAMINATION: (This included age, sex, height, weight, temperature, 
EENT, pulse, respiration, blood pressure, general 
appearance, skin, head, neck, chest, heart, lungs, 
abdomen, genitalia, lymphatics, blood vessels, locomotor, 
extremities, neurological, musculature, rectal) 
IMPRESSION: 
Appendix 3 
SUBJECT IDENTIFICATION FOR SCHEDULING 
SUBJECT NUMBER SUBJECT NAME 
I B.E.H. 
HOSPITAL 
NUMBER 
70-0-l 9 
2 M.4.C. 70-O-20 
3 R.S.H. 70-o-21 
4 G.S.R. 70-o-26 
5 J.A.H. 70-o-22 
6 A.C. I. 70-O- 18 
7 ‘A’. F.M. 70-o-24 
8 A.P.K. 70-o-23 
9 R.R.T. 70-o-27 
10 C.E.R. 70-O-25 
11 L.F.E. 70-o-28 
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DAILY ACTIVITY RECORD - 
SUBJECT ACTIVITIES AND BEDSIDE OBSERVATIONS 
DATE 
NAME START 
SUBJECT NO. END 
TIME I OBSERVATION I INITIAL 
0700 - 0800 
0800 - 0900 
0900 - 1000 
1000 - 1100 
1100 - 1200 
12io - 1300 
1300 - 1400 
1400 - 1500 
1500 - 1600 
1600 - 1700 
1700-1800 
1800 - 1900 
1900 - 2000 
2300 - 2100 
2100 - 2200 
2200 - 2300 
2300 - 2400 
2400 - 0100 
0100 - 0200 
0200 - 0300 
0300 - 0400 ~. 
0400 - 0500 
05bO - 0600 
ok00 - 07001 I 
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SUBJECT 
SUBJECT NO. 
FLUID INTAKE 
Record 
START 
END 
DATE TIME 
TIME ORDERLY INITIAL VOLUME (ml. ) 
Twelve hour total ------------------- 
Twenty-four hour total 
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URINE STUDIES 
URINE OUTPUT 
Record 
Appendix 
DATE TIME 
NAME START 
SUBJECT NO. END 
Six hour total! 
Six hour total 1 
Six hour total-1 
Six hour total) 
6.1 
TWENTY-FOUR HOUR TOTAL ------_---------------- 
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17-HYDROXYCORTICOSTEROID TECHNIQUE 
A complete 24-hour specimen of urine is collected and the 
volume determined. Instructions for this collection are as follows: 
1 st day - (a) Up on arising, empty bladder (discard urine) record 
time. 
(b) All subsequent urine goes into collection bottle. 
(c) Keep bottle on ice or in refrigerator. 
2nd day- (d) S t I e a arm for same time as (a), add this voiding to 
collection bottle. 
(In other words, discard first morning’s sample, save 
second morning’s sample.) 
Following the measurement of total volume, a 75-cc aliquot 
of urine is frozen until the determination, and the remainder is discarded. 
PROCEDURE: Hydrolysis 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
Set up 250-ml E I r enmeyer flasks for the following: 
Two H20 blanks, marked 1 & 2; the number of flasks required 
to run each sample (the first sample is marked 7). Flasks 3 - 6 
will be picked up on the second day of the determination. 
Weigh into each of the above flasks the following: 
25 mg of Ethylediamine Tetraacetic Acid (Versene) 
40 mg of L-Cysteine HCL (Cysteine) 
With a 10 ml vol 0 ppt. add to the H20 blanks 10 ml of deminer- 
alized H20. 
Using a 10 ml vol. ppt. add 10 ml of urine to all samples. Use a 
new ppt. for each. 
With a 10 ml serological ppt. add to each flask 1 ml of 1 M phos- 
phate buffer of pH 6.65. 
Swirl each flask by hand to mix solutions. 
With a 10 ml serological pptO add 1 ml of B-gluceronidase solu- 
tion to each of the flasks. Swirl by hand. 
With a 10 ml sero. ppt. or a burette add 1.5 ml or redistilled 
CHCL3 to each flask and swirl. (This CHCL3 must be distilled 
freshly each day.) 
9. Cover each flask with a tissue held securely with a rubber band. 
10. Place all flask in incubater for either 4 hours or overnight at 370~. 
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Extraction 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
Remove flasks from incubator. 
Set up flasks numbered 3 - 6. 
#3 is the third H20 blank, which does not go through hydrd- 
gys- 6 are standards which begin from extraction. 
Set up 6 conical-tip glass-stoppered centrifuge tubes (50 ml) 
for standard recovery. Mark 3 of the tubes with an S, and the 
other three with OS. 
With a i ml vol. ppt. add 1 ml of standard (20 ug/ml in ethanol). 
to flasks 4,5,& 6 and tubes S and @S (ail six tubes). 
Evaporate to dryness in a water bath at 370 C with air. 
Once dried, stopper the six tubes and place in refrigerator. 
Usinga 1Oml Vol. ppt., 
flasks 3 .. 6. 
add 10 ml of demineralized H20 to 
Add 90 ml of redistilled CH2CL2 to each flask, #l - #X. Cover 
immediately with foil to avoid evaporation. 
Carefully place all flasks on rotating table and extract for 20 min. 
at 48 rpm. Freeze overnight or for several hours until water and 
urine are solid. 
Transfer of Volumes and Color Development 
20. Set up 125 ml separatory funnels equipped with teflon stopcocks, 
one for each flask in extraction. Beneath each funnel set up a 
125 ml erlen. flask with a funnel (plain-stem) which has been 
loosely packed with Pyrex wool. (Do not pack walls) Put one 
teaspoon sodium sulfate in each funnel. 
21. Set up two rows of 50 ml conical tip tubes, one set for each 
sample. Mark the first row @l - @X and the second row 1 - X .* 
22. Into each tube in the front row (@) put 3.0 ml H@E reagent; 
into each tube in the back row put 3.0 ml HE reagent. Set aside. 
23. Remove extraction flasks, not more than 6 at a time, from the 
freezer. 
24. Carefully transfer the CH2CL2 from each flask into its respective 
Sep. funnel by pouring it over the ice, making certain that none 
of the liquid is left behind. 
25. Add to each Sep. funnel 5.0 ml of 0.1 N NaOH for washing. 
Stopper the Sep. funnels and invert for 20 seconds, releasing 
pressure frequently. Remove the stoppers and allow the two 
phases to separate. 
26. Now filter the CH2CL2 through the sodium sulphate into its 
receiving flask, leaving the NaOH behind. Cover receiving 
flasks with foil. 
27. From each receiving flask, measure out 40 mls into each of the 
* Standard tubes: Into each @S tube, 3.0 ml of H@E; into each S tube, 
3.0 ml HE. Also set up two tubes to hold the reagents alone, as a 
purity check; 3.0 ml into each. 
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respective 50 ml tubes, @ and non-@. Stopper tubes imme- 
diately. 
28. With all stoppers tightly fitted, shake tubes 3 times for 20 
seconds. Rotate Standard tubes three times. 
29. Centrifuge tubes, with stoppers removed, for 10 minutes at 
2000 rpm. 
30. Aspirate the top layer, CH2CL2. Cover the open tubes with 
a towel or foil and place in a dark place overnight to develop 
color. 
31. Read on Beckman DU at 410. 
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TIME 
FECES COLLECTION SHEET 
DATE 
NAME START 
SUBJECT NO. END 
I I I 
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8. FLUID AND ELECTROLYTE STUDIES 
PLASMA VOLUME TECHNIQUE 
TECHNIQUE OF l-131 OR l-125 
HSA BLOOD VOLUME 
A. Dilution of Stock Solution 
1. Determine volume of stock solution that will contain 100 UC 
of l-131 or 300 UC of I-125. 
Volume = 
100 UC 
uc/ml as on shipping notices assay x decay factor 
DECAY FACTOR TABLE 
Days l-l 31 Factor I-l 25 Factor 
1 0.918 0.988 
2 0.843 0.977 
3 0.774 0.964 
4 0.711 0.952 
5 0.653 0.942 
6 0.600 0.930 
7 0.551 0.919 
8 0.506 0.907 
9 0.465 0.897 
10 0.427 0.886 
2. Dilute this volume to about 50 ml using stock solution of 
sterile normal saline to which 1 ml of HSA (250 mg) has 
been added. A sterile multiple injection bottle should be 
used. We find it convenient to use a 30 ml bottle of 
sterile saline, e.g. Cutter’s Ambot 30 cc normal saline 
USP for injection. 
B. Preparation of Standard: 
1. Draw off 1 ml of this diluted stock solution using a sterile 
disposable plastic syringe and a #21-l inch needle. Remove 
the needle. Glass syringes require the use of larger vol- 
umes, e.g. 5 ml. 
2. Wash this 1 ml of stock solution into tap water contained in 
a 1000 ml volumetric flask. The syringe should be washed 
twice with the water contained in the flask. 
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C. Procedure on Patient (Note alternate procedure) 
D. 
3. Mix by gently agitating the flask. 
4. Dilute with water to the 1000 ml mark and mix again, 
5. Using a 1 ml volumetric pipette, measure out 1 ml into 
two tubes used for counting in a scintillation well-counter. 
6. Determine the radioactivity in each tube using a scintilla- 
tion well-counter. Count for at least 10,000 counts. 
7. If the counts per minute obtained vary by less than 1 percent 
between any of the two tubes, stopper the tubes with corks 
and use for standards whenever a plasma volume is to be 
determined using this stock solution. 
8. If the counts obtained vary by more than 1 percent between 
the two tubes, repeat steps B (5) through (7). 
1. A sterile 1 ml syringe is filled through a #21-l” needle to 
the 1 ml mark with the stock solution in the exact same way 
used for the standard. Do not remove the needle which is 
used for the patient. 
2. If the patient has received a previous tracer dose of radio- 
active isotope or if there is any doubt about it, a 10 ml blood 
specimen is drawn into an oxalated or heparin tube and 
shaken. This will be used for determining background 
activity. 
3. Inject the 1 ml of stock IHSA into an arm vein, then aspirate 
a syringe full of blood and reinject this to flush the syringe 
of all radioactivity two times. NOTE: It is crucial that all 
the radioactivity be injected into the blood stream since any 
albumin injected into the subcutaneous tissues will not reach 
the plasma for several hours. 
4. Ten minutes later, draw a 10 ml blood specimen and place in 
a heparin or oxalate tube. 
Laboratory Procedure (Before working with the blood, mix it thoroughly) 
1. Determine the hematocrit of each blood specimen. 
2. Centrifuge and remove the plasma from each blood specimen. 
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3. Pipette 1 ml of blood from each blood specimen into each 
of two well-counter tubes, using a volumetric pipette. 
4. If a background specimen of blood is necessary, perform 
steps 1 through 4 on it. 
5. Count these specimens and the standards in a scintillation 
well-counter. Routinely, a count of 10,000 is satisfactory. 
6. During pipetting, the detector background should be obtained. 
E. Calculations 
1. The counts per minute of background for room or plasma are 
determined. 
2. The counts per minute of each blood sample and each stan- 
dard are determined. The corrected counts per minute = crude 
counts per minute minus background. 
3. The corrected counts/minute are averaged for the 2 blood 
specimens, and also for the 2 standards. 
4. The plasma volume is ml is expressed as follows: 
B.V. = ml IHSA Solution lniected x Average of Corrected Std. x Dil. of Std. 
Average of Corrected Counts of Blood 
5. Plasma volume is obtained by multiplying the blood volume by 
one minus hematocrit expressed as a decimal or it can be obtained 
directly by using plasma instead of blood in Step D-#3. 
Some of the errors inherent in this method have been discussed by 
Hlad, et. al. He notes as have others, that the biggest source of error 
is in the syringe. W e h ave found that plastic syringes and making up 
the standard dilution with a syringe using the exact same technic used 
for injecting the patient corrects most of the problem. 
CALCULATION OF A TYPICAL BLOOD VOLUME 
10 UC of l-l 25 iodinated human serum albumin. 
Standard diluted - 1 :lOOO 
Counting time - 3 minutes per sample 
Mean air background - 2481/3 minutes 
Standard ‘Ount - #l _ 1341 g/minute 
#2 - 13495/minute 
Mean 13135 - 2481 = 10,654/3 minutes 
Plasma Volume = 
13629 x lo3 
355 1 = 38,3B . 
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TECHNIQUE OF RED CELL MASS 
A. Bottles, made specially for sodium chromate red cell survival tests, 
are now available containing acid citrate dextrose solution. 
These bottles may be used or if this is not possible you may use any 
sterile stoppered container with a multiple injection top. It has 
been found that acid citrate dextrose producesa higher percentage 
of tagging than do other anticoagulants, e.g. heparin or oxalate. 
Even so, heparin and oxalate are perfectly adequate for the use in 
this test. 
B. Approximately 50 ml of blood are withdrawn from the patient and 
injected into the bottle containing the ACD solution. 
C. 100 -150 mc of sodium chromate are injected into the bottle. 
(Sodium chromate gradually deteriates if it is placed in the bottle 
prior to the addition of the blood). 
D. The bottle is agitated gently and maintained at 370 for 15 to 30 
minutes. 
E. At the end of that time 0.5 gm of Vitamin C is added to the bottle. 
and the bottle is gently stirred. 
F. Exactly 20 ml of this blood is removed with a sterile syringe and 
reinjected into the patient. Enough blood is kept within the tag- 
ging bottle to determine a hematocrit and the counts per minute 
in the cells and plasma. 
G. Approximately 6 ml of this blood is removed and centrifuged. Two 
ml of plasma is pipetted into a 1,000 ml volumetric flask already 
containing water and a few ml of O.lN HCL. Two ml of blood are 
pipetted into a second volumetric flask also containing HCL. 
H. Two, 1 ml samples are obtained from each volumetric flask and 
placed in counting bottles and the radioactivity in each counting 
bottle is determined. 
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I. Ten minutes after the chromate has been injected into the patient a 
6 or 8 ml venous blood specimen is obtained. One ml aliquots of 
the plasma and blood are counted and a hematocrit determined. The 
red cell mass is determined by the following formula: 
Red Cell Mass = 
Red Cell Radioactivity of Std. x ml injected x Dilution 
Red Cell Radioactivity at 6 minutes 
(Cts/min BI - Cts/ 
Red Cell Mass =- 
min Plasma Std.) x 1 -Hematocrit x 
(Cts/min BI at 10 min) - (Cts/min Plasma) x 
20 x Hematocrit at 10 min 
(1- Hematocrit at 10 min x Hematocrit 
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EXTRACELLULAR FLUID SPACE TECHNIQUE 
EXTRACELLULAR SPACE DETERMINATION USING S-35 O4 
Extracellular is defined as all tissue fluid lying outside of cell 
walls. This includes plasma, interstitial, cerebrospinal, peritoneal, 
pleural, pericardial and synovial fluids, ocular humor, urine and all 
glandular secretions. Diffusion of ions and water into some of these 
fluids occur at rates considerably slower than the diffusion between 
plasma and interstitial fluid. In most calculations of extracellular 
fluids, areas with slow diffusion rates are excluded by obtaining samples 
before these more slowly diffusing compartments have reached equili- 
brium with the remaining interstitial fluid. Different tissues vary in 
their relative proportions of extracellular water. As an example, skin 
contains more extracellular water than does muscle. However, the 
proportions of extracellular water and intracellular fluid are similar 
enough to consider all fluids of the body as a single system. 
The earliest recorded method for measuring extracellular fluid 
was the estimation of the spaces between cells in frozen cross-sections 
of muscle. Since thot time, the early distribution spaces of sodium, 
chloride, bromide, thiocynanate, thiosulfate, insulin, sucrose mannitol 
and sulfate have been used for this determination. An ideal tracer for 
measuring extracellular fluid should reach equilibrium rapidly and should 
not enter cells or bind to proteins. Of the available methods, the sulfate 
ion appears to be the most ideal ion for measuring extracellular fluid. 
Its chief advantages are that it has a short biological half life, is excreted 
almost entirely by the kidneys, is only slightly metabolized and reaches 
equilibrium within 18 minutes. Radiosulfate is known to equilibrate with 
peritoneal, pleural, and pericardial fluids. A small amount is found in 
gastric juice, sweat, cerebrospinal fluid, bile and other gastro-intestinal 
fluids. It is not known whether it enters lymph, synovial fluid or occular 
humor. After its initial equilibrium in the extracellular fluid, limited 
amounts of sulfate enter erythrocytes and other body cells. Some of it is 
bound by serum proteins. Kidney excretion of sulfate is rapid with about 
50% of a tmcer dose excreted in the first 6 hours. The renal clearance of 
sulfate is nearly constant allowing an estimate of renal excretion to be sub- 
stituted for actual collection of urine. Most authors consider urinary excre- 
tion to be 4-8% of the administered dose. Less than one percent appears 
in the stool. There is a diurnal variation in the sulfate space. Daytime 
ECF is about 7.5% smaller than a night time value for ECF. 
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The sulfate space may be determined by plotting the values of 
hourly blood samples on semilogarithmic paper and extrapolating this 
line back to zero time. An alernate method is to collect two hourly 
urines. The sulfate excreted in these urines is subtracted from the total 
injected radioactivity. The disadvantage of the method where the values 
are plotted is that the determination requires four hours to be completed. 
The disadvantage of the urinary collection method is the difficulty of 
obtaining accurate urine samples. If one’s time is available, plotting 
the blood samples would seem to be the better of the two methods. In 
the methods to be described, a probable error of 2 5% is possible. 
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THE SIMULTANEOUS TOTAL BODY WATER, 
EXTRACELLULAR FLUID, INTRACELLULAR FLUID, 
AND PLASMA VOLUME TECHNIQUE 
It is convenient to make up solutions to be injected in a 30 ml 
volume of sodium chloride injections, USP, with a multiple dose stopper 
(e.g. Ambot, Cutter Laboratories, California). 
FORM RADIOISOTOPE 
Water H-3 
Sodium Sulfate s-35 
Albumin l-131 or l-125 
CONVENIENT 
CONCENTRATION 
300 uc/ml 
50 uc/ml 
25 uc/ml 
PATIENT: 
1. 
2. 
3. 
4. 
5. 
6. 
A 5 ml heparinized blood sample is obtained from a non- 
fasting well hydrated patient. This is labeled BACK- 
GROUND SULFATE. The patient is told to empty his 
bladder and discard the urine. 
Fifty UC of sodium sulfate containing S-35 is injected 
intravenously. 
Ten ml heparinized blood samples are drawn at 20, 40, 60, 
120, 180, and 240 minutes. The patient is asked to empty 
his bladder to collect the urine excreted during the first 
and second hours. The urine volumes are recorded. The 
urine samples are labeled one and two hour sulfate urine. 
Ten UC of radioiodinated serum albumin and 300 UC of tri- 
trated water are injected intravenously. 
Ten minutes later 10 ml of heparinized bloal is obtained 
for plasma volume. This is labeled ten minute plasma. 
The urine excreted during the third hour is collected. This 
sample’s volume is measured and it is labeled TBW back- 
ground urine. 
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7. Three separate urine specimens are obtained over the next 
four hours to use for body water. Timing of these urines 
is not critical. If urine is inconvenient to obtain, 2 l/2-4 
hour blood samples can be used. The urines are labeled 
TBW urines 81, #2, x3, 
PREPARATION OF BLOOD SAMPLES: All blood samples are centrifuged 
and the plasma removed. 
1. Duplicate 1 ml plasma aliquots from the background plasma 
and 10 minute plasma samples are pipetted into counting 
tubes and the radioactivity measured with the plasma stan- 
dard in a well-counter. 
2. A. Duplicate 1 ml aliquots background sulfate and the 20, 
40, 60, 120, 180, and 240 minute sulfate bloods are 
pipetted into clear test tubes. One ml of 40% tri- 
chlorcacetic acid is added to each tube. 
B. The solutions are stirred, care being taken to keep the 
precipitate from adhering and drying to the side of the 
test tube. 
C. The tubes are centrifuged for about 20 minutes. 
D. The supernatent is removed making sure that flakes of 
the precipitate are not included since these contain 
the radioiodinated serum albumin. 
E. Duplicate one-tenth ml samples of each are pipetted 
into counting bottles and 15 ml of diatol scintillation 
solution is added to each bottle. The solutions are 
mixed and the radioactivity measured. 
3. Body water is determined free of other activity by distilling 
the samples. 
A. About 3 ml of each urine sample is added to 25 ml 
Erlenmeyer flasks containing boiling chips. 
B. Single hole is made in multiple injection type stopper 
so a glass tube with a 20° angle can be inserted into 
the stopper. The cooling arm of the glass tube should 
be long enough to allow collection of the distillate in 
a test tube. 
C. The flasks are heated at low heat on a hotplate. The 
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samples are boiled slowly until one-half ml of dis- 
tilled water has been collected from each. 
D. One tenth ml aliquots of the distillate are placed in 
counting bottles. 
E. 15 ml of diatol scintillation solution is added to each 
counting bottle and the solutions are mixed. The 
radioactivity is determined. 
4. If plasma is used rather than urine for the body water, the 
following procedure is followed: 
A. The plasma sample is placed in a large test tube with 
a multiple injection stopper in which an angledglass 
tube is inserted. 
B. The test tube is placed in an Erlenmeyer flask and 
placed on a hot plate. 
C. The flask is heated to coagulate the protein. Any dis- 
tillate produced is collected. 
D. The test tube is removed, centrifuged and the water 
removed. 
E. The protein free water is placed in a small test tube and 
treated in the same way as a urine specimen. 
NOTE: Blood, because of its high protein content is more difficult to distill 
than urine. A 10 ml blood sample produces only about 0.1 ml of distillate. 
DIATOL COUNTING SOLUTION: 
Toluene 500 ml 
Dioxane 500 ml 
Methanol 300 ml 
2,5-Diphenyloxazole (PPO) 6 gm 
1,4-bis-2-( 5 Phenyloxazolyl) Benzene 150 mg 
Napthalene 100 gm 
The solutions are mixed and placed in an automatic filling and leveling buret. 
STANDARDS: Plasma 
1. Ten UC of radioiodinated serum albumin solution are pipetted 
into a one liter volumetric flask half filled with water. The 
flask is filled to the one liter mark with water and the flask 
is shaken. 
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2. 
STANDARDS: Sulfate 
1. One ml of the injectable radioactive sulfate solution is 
placed in a half full 100 ml volumetric flask which is then 
brought to volume. The flask is shaken. 
2. 
3. 
STANDARDS: 
1. 
2. 
3. 
Two, one ml aliquots are removed and placed in counting 
tubes. These aliquots must be removed immediately 
because albumin absorbs into the glass. If the samples can- 
not be removed immediately, stable albumin should be 
added to the volumetric flask, prior to adding the radioac- 
tive albumin. 
Triplicate one tenth ml samples are placed in counting bottles. 
Fifteen ml of diatol scintillation solution are added, the 
samples are shaken. 
Radioactive Water 
One ml of the injectable water solution is placed in a half- 
full 100 ml volumetric flask which is then brought to volume. 
The flask is shaken. 
Triplicate one tenth ml aliquots are added to counting bottles. 
Fifteen ml of diatol solution is added and the solutions mixed. 
CALCULATIONS: Plasma Volume 
ncpm Std x 1000 x ml injected 
ncpm 1Omin. plasma -ncpm bk gd plasma 
= 10 min. plasma space 
CALCULATIONS: Extracellular Fluid Space 
ncpm Std x 100 x ini. - ncpm ml sulfate 1 hr urine x vol.- 
ncpm 60 min. sulfate plasma - ncpm bk gd sulfate 
- 60 min. sulfate space 
(ncpm Std x 100 x ml ini.) - (cpm/ml 1 h rurinex vol. + cpm/mi 2hrurinex vol.)= 
ncpm ml plasma - ncpm bkgd plasma 
= 120 sulfate space 
The best results are obtained if you mean these two values. 
CALCULATIONS: Alternate Sulfate Space 
1. Plot the ncpm/ml sulfate on semilogarithmic paper with cpm 
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on the log scale and time on the linear scale. Extrapo- 
late the line to zero time. 
(ncpm Std x 100 x ml injected) = 
ncpm zero time 
sulfate space 
CALCULATIONS: Body Water 
The mean value of the three urine determination are used. 
ncpm Std x 100 x ml/inj. 
ncpm urine sample - ncpm background urine 
= 3 hour water space 
ncpm = net counts per minute 
Bkgd = background 
CALCULATIONS: Intracellular Fluid 
Total Body Water = Extracellular Fluid + Intracellular Fluid 
CALCULATIONS: Lean Body Mass 
TBW 
0.718 
= Lean Body Mass 
Total Weight = Lean Body Mass + Total Body Fat 
NORMAL VALUES: 
% of Body Weight 
Plasma Volume 
Extracellular Space 
Total Body Water 
Intracellular Fluid 
Male Female 
See N omogram 
23 23 
54 49 
31 26 
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RADIOISOTOPE SCHEDULE 
DAK 
- __-- -- 
SUBJtCT NUMBtR TESTS 
6-9-64 1.2 3 4 5 6 7 8 9 10 11111,111 
6-l 5-64 1,2,3,4,5,6,7,8,9,10 
6-l 9-64 I,%%45 
6-20-64 6,7,8,9,10 
6-22-64 1,2,3,4,5 
6-23-64 6,7,8,9,10 
6-28-64 1,%3,4,5 
6-29-64 6,7,8,9,10 
6-29-64 1,2,3,4,5 
6-30-64 678910 I II I 
7-8-64 1,2,3,4,5,6,7,8,9,10 
7-2 l-64 1,2,3 4 5 6 7 8 9 10 111,111 
7-23-64 1,2,3,4,5 
7-24-64 1,2,3,4,5 
7-24-64 6,7,8,9,10 
7-25-64 1,2,3,4,5,6,7,8,9,10 
7-26-64 12345678910 111111rt1 
7-27-64 1 2 3 4 5 6 7 8 9,lO I I I I I I I I 
7-28-64 6,7,8,9,lO 
8-2-64 1,2,3,4,5 
8-3-64 6,7,8,9,10 
8-3-64 1,2,3,4,5 
8-4-64 6,7,8,9,10 
P.V., RBCM, Hgb, Hct, ECF, TBW 
P.V., RBCM, Hgb, Hct, ECF, TBW 
P.V., RBCM, Hgb, Hct, ECF, TBW 
P.V., RBCM, Hgb, Hct, ECF, TBW 
P.V., RBCM, Hgb, Hct, ECF, TBW 
P.V., RBCM, Hgb, Hct, ECF, TBW 
P.V., RBCM, Hgb, Hct, ECF, TBW 
P.V., RBCM, Hgb, Hct, ECF, TBW 
P.V., Hgb, Hct (Pre & Post Tilt) 
P.V., Hgb, Hct (Pre & Post Tilt) 
P.V., ECF, Hgb, Hct 
P.V., ECF, Hgb, Hct 
P.V., Hgb, Hct (Pre & Post Tilt) 
P. V., Hgb, Hct 
P.V., Hgb, Hct (Pre & Post Tilt) 
P.V., Hgb, Hct 
P.V., Hgb, Hct 
P.V., ECF, Hgb, Hct 
P.V., ECF, Hgb, Hct 
P.V., ECF, Hgb, Hct 
P.V., ECF, Hgb, Hct 
P. V., Hgb, Hct (Pre 8, Post Tilt) 
P.V., Hgb, Hct (Pre 8, Post Tilt) 
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DATE SUBJECT NUMBER TESTS 
8-l 9-64 1,2,3,4,5,6,7,8,9,10 P.V., RBCM, Hgb, Hct, ECF, TBW 
8-27-64 1,2,3,4,5 P.V., Hgb, Hct (Pre & Post Tilt) 
8-28-64 6,7,8,9,10 P.V., Hgb, Hct (Pre 8, Post Tilt) 
8-28-64 1,2,3,%5 
8-29-64 6,7,8,9,10 
8-31-64 1,2,3,%5 
9-l -64 6,7,8,9,10 
9-6-64 1,2,%%5 
9-7-64 6,7,8,9,10 
P.V., Hgb, Hct, RBCM, ECF,. TBW 
P.V., Hgb, Hct, RBCM, ECF, TBW 
P.V., Hgb, Hct, RBCM, ECF, TBW 
P.V., Hgb, Hct, RBCM, ECF, TBW 
P.V., Hgb, Hct, RBCM, ECF, TBW 
P.V., Hgb, Hct, RBCM, ECF, TBW 
9-7-64 1,2,3,4,5 
9-8-64 6,7,8,9,10 
P. V., Hgb, Hct (Pre 8, Post Tilt) 
P.V., Hgb, Hct (Pre & Post Tilt) 
“P.V.: I 
125 
RISA Plasma Volume 
RBCM: Cr51 1 Red Blood Cell Mass 
ECF: S35 - Sodium Sulfate - Extracellular Fluid 
TBW: H3 - Tritium - Total Body Water 
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8.6 
RADIOISOTOPE STUDIES 
RESULTS SUMMARY SHEET 
SUBJECT SUBJECT NO. 
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I 
BODY WEIGHT RECORD 
NAME SUBJECT NO. 
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LEG CIRCUMFERENCE MEASUREMENT RECORD 
- ._ 
SCBJECT -- _ SUBJECT NO. -- _- ---.- 
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PSYCHOPHYSIOLOGICAL STUDIES 
The Effects of Exoerimentallv Induced Bed Recumbency 
on 
Psychophysiological Functioning 
Within the framework of the total investigation, it was 
possible to study a broad range of psychophysiological and behavioral 
changes as a function of restricted activity and its associated physiologi- 
cal effects. The choice of variables was directed by theoretical con- 
siderations involving the effect of restricted activity upon the pattern 
and level of proprioceptive input with associated changes in muscle tonus, 
generol arousal level, ond vascular control mechanisms. One battery of 
tests involved psychologic and behavioral variables presumed to reflect 
an altered arousal level induced during bedrest. A second battery con- 
cerned variables reflecting sensorimotor performance which were invest- 
igated with respect to cardiovascular changes induced by passive body 
tilt both before and after the bedrest periods. 
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11.1 EXPLANATIONS OF TESTS 
PREDICTOR VARIABLES 
The following variables were examined for relationships 
to both psychological and physiological changes which occurred as a 
function of prolonged bed recumbency. All tests in this group were 
administered before the subjects began their first period of bedrest. 
11.1.1.1 Personality Factors. Personality traits were assessed 
using Cattell’s Sixteen Personality Factor Inventory, a 374-iten ques- 
tionnaire. The test is scored on the following sixteen bi-polar factors 
which have been derived through factor analytic techniques: 
a. 
b. 
C. 
d. 
;: 
9. 
h. 
i. 
I* 
k. 
I. 
m. 
n. 
0. 
(See test 11.2. P, 
schizothymia - cyclothymia 
low “g” - high “g” (general intelligence) 
low ego strength - high ego strength 
submissiveness - dominance 
desurgency - surgency 
low superego - high superego 
threctia - parmia 
harria - premsia 
alaxia - protension 
praxernia - autia 
artlessness - shrewdness 
assurance - guilt proneness 
conservatism - radicalism 
group adherence - self sufficiency 
low integration - high self-concept 
low ergic tension - ergic tension 
11.1.1.2 Modes of Aggressivity. A thematic projective test was 
used to assess individual differences in characteristic manner of dealing 
with aggression. The test consisted of seven pictures, depicting people 
in various situations, that were presented sequentially on slides. The 
subject was given five minutes to compose a story concerning each 
picture. 
These pictures were designed especially to elicit themes 
having to do with hostile aggression and aggressive activity in the sense 
of assertiveness. Stories were analyzed by three psychologists who pro- 
vided independent ratings of story-content on a number of conceptually 
related dimensions, including degree of hostile aggression, direction of 
aggressive action (against hero or against others), level of activity 
expressed, passivity vs. assertiveness, and presence of anxiety or guilt. 
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Previous investigators have reported a relationship between 
scores on a similar instrument and tolerance for g-stress in a human 
centrifuge. They have suggested that the subject’s characteristic affec- 
tive reaction under stress (“anger in” vs. “anger out”), which is presum- 
able reflected in his thematic test responses, may be associated with a 
relative epinephrine / noreponephrine preponderance that could be the 
biochemical mechanism accounting for differences in cardiovascular 
response to g-stress. (See test 11.2.2) 
11.1.1.3 Activity Level. A pool of questionnaire items which define 
a general activity and energy factor was taken from the Guilford-Zimmerman 
Temperament Survey. The test was used to distinguish between persons 
having a disposition to engage in vigorous overt action and those with a 
tendency toward inertness and disinclination for motor activity. It was 
hypothesized that differences in reaction to an extended period of inacti- 
vity should be related to the subiects’ need for activity. (See test 11.2.3) 
11.1.1.4 Kinesthetic After - Effect. Repeated estimations of size on 
the basis of kinesthetic cues were obtained prior to and following intervals 
of kinesthetic satiation. Individual differences in kinesthetic after-effects 
have been shown to be predictive of the ability to tolerate sensory depriva- 
tion involving multiple modalities. Extent and persistence of satiation 
effects have also been found to correlate with extroversion and intolerance 
for sensory deprivation. (See test 11.2.4) 
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BED RECUMBENCY BATTERY 
These variables were selected to assess changes in be- 
havior which might occur as a function of physical inactivity and con- 
finement during extended bedrest. The wealth of available physiological 
information also permitted study of the correlation between observed 
psychological and physiological changes during the bedrest periods. 
While there have been numerous studies concerned with the effects of 
sensory deprivation involving multiple modalities, there has been a 
paucity of studies concerned with the effects of physical inactivity and 
confinement per se. Since both of these factors have been commonly in- -- 
volved in more totalisitic deprivation studies, it is particularly important 
that their psychological and psychophysiological effects be evaluated. 
The few studies which are relevant have involved a restricted range of 
variables largely limited to psychomotor measures. Lacking precedence 
for studying the effects of extended bedrest, variables relevant to affect- 
ive, preceptual and cognitive processes were examined in this study. A 
dual theoretical rationale contributed to the selection of variables. Some 
were chosen which might be sensitive to shifts of arousal away from optimai 
levels as a function of proprioceptive deprivation. Other variables were 
included which might reveal affective stress responses as a function of in- 
activity and confinement. 
These criterion tests were administered prior to, during, 
and in some cases, immediately following the three 10 day periods.’ A 
portion of the tests were administered to a control group matched for av- 
erage age and education level. The control subjects followed their normal 
routine during the period in which the tests were administered. Otherwise, 
the circumstances within which the tests were presented were comparable 
to the experimental group. An asterisk after the variable listing indicates 
a similar assessment for the control group. 
11.1.2.1 Mood Changes*. To obtain a subjective measure of daily 
mood fluctuations, the Clyde Mood Scale was administered once in the 
morning and once in the afternoon. The Mood Scale, a 48-adjective 
check list, was quantified in terms of the following dimensions obtained 
from previous factor analyses: 
a. Sociabi I ity 
b. aggressivity - hostility 
CO intellectual dysfunction 
d. arousal level 
it- 
anxiety - depression 
somatic expression (See test 1 1.2.5) 
11.1.2.2 Overt Behavior. To assess behavioral changes, a rating 
scale was devised consisting of four dimensions which have relevance to 
i 
See Schedule of Test Administration 
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the immobilization situation. The deminsions under observation were: 
a. level of arousal 
b. sociability 
C. affective expression 
d. positiveness of attitude toward experiment 
Subjects were rated during periods that cover all their waking hours by 
a total of six raters. In order to determine the concordance among these 
raters, four of them made observations for the same period of the day. 
(See test 11.2.6) 
11.1.2.3 Perceptual Functioning. Three measures of perceptual 
function were administered. These functions have been studied in 
previous investigations of short-term immobilization, and changes have 
been observed in some instances. 
a. Two-point discrimination thresholds were deter- 
mined to assess changes in tactile acuity. Measurements were obtained 
by applying needles to the forearm according to the “stair-case” psycho- 
physical method. (See test 11.2.7) 
b. *The rate at which an ambiguous figure (Necker 
Cube) was perceived to undergo apparent reversals during three 1 -min- 
ute trials per testing session was monitored. (See test 11.2.8) 
C. *Speed and accuracy of visual-motor response 
was tested by having the subject cross out those numbers in a given row 
which corresponded to a number encircled at the beginning of the row. 
(See test 11.2.9) 
11.1.2.4 Mental Alertness. *Changes in word fluency were assessed 
to index the mental alertness of each subiect. Two letters of the alphabet 
were presented at each session, and subjects were instructed to name as 
many words as possible beginning with that letter during a l-minute inter- 
val. (See test 11.2.11)) 
11.1.2.5 Projective Apperception. *Both before and during the 
three bedrest periods, subsets of the Holtzman Inkblot Test were adminis- 
tered. Responses were analyzed for level of integration of the percepts 
to assess alterations in ideational organization and spontaneous invest- 
ment of psychic energy. In addition, a corollary of one of the funda- 
mental Rorschach postulates was tested. This hypothesis states that there 
is a reciprocal relationship between the opportunity for mobility and pro- 
pensity to perceive apparent movement in an unstructured stimulus. 
(See test 11.2.11) 
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11.1.2.6 Attentional Orientation. A verbal projective technique 
was used to probe the salient content of the subiects’ immediate awareness. 
The subject was required to list twenty items of which he was immediately 
aware, i.e., currently experiencing. Among other content areas, the 
subjects’ reports were analyzed for extent of somatic preoccupation VS. 
orientation toward external environmental events. (See test 11.2.12) 
11.1.2.7 Physiological Functioning. The following physiological 
variables were examined in termsof therr relationship to cognitive, emo- 
tional, perceptual, and sensorimotor performance. Heart rate and pulse 
pressure were analyzed in terms of their direct relation to psychological 
measures, while blood volume and hematocrit were treated as indices of 
variables which affect overt behavior. 
a. Cardiovascular responses to the tilt procedure, 
prior to and following the bedrest periods, were correlated with reaction 
time measures obtained immediately preceding and following the tilt 
test. Prolonged bed recumbency results in decreased demand for musculo- 
skeletal supporting reflexes and cardiovascular postural reflexes-mechanisms 
involved in circulation of the body fluids. If these mechanisms are im- 
paired, cerebal circulatory insufficiency may alter sensorimotor coordina- 
tion. Heart rate and pulse pressure variables obtained before, during and 
after tilt were used as indices of cardiovascular functioning. In addition, 
comparisons of responses to tilt obtained prior to and following bedrest 
periods, reflecting the effects of bedrest on cardiovascular homeostatic 
mechanisms, were correlated with measures of psychological adjustment 
to bedrest. 
The lability of heart rate and pulse pressure responses 
obtained during the simple and complex tilt procedures was scrutinized 
for correlation between lability and mean response latency obtained in 
reaction time measures. These physiological variables were also examined 
in relation to the temporal growth and decay of readiness to respond as 
determined by the latency associated with different foreperiod intervals. 
b. Blood volume was used as an index of possible 
cerebral circulatory insufficiency which would affect measures of mental 
alertness. 
C. Hematocrit was examined for changes indicating 
a state of physiological fatigue which could affect measures of percep- 
tual, intellectual, and emotional behavior. 
11.1.2.8 Subject Evaluation of the Experiment. At the termination 
of each 1 O-day bedrest period, a 148-item questionnaire was administered. 
The questions were grouped into seven categories: 
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a. attitudes toward the experiment 
b. somatic preoccupations 
C. evidence for cognitive dysfunction 
d. affective responses 
f”. 
characteristics of time perception 
types of dreams and fantasies 
!3* feelings of interpersonal isolation 
(See 11.2.13) 
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TILT BATTERY 
In addition to those variables listed in the original pro- 
tocol, psychophysiological studies were conducted to evoluate those 
cardiovascular parameters which relate to a change in sensorimotor per- 
formance. It was recognized that studies of cardiovascular deconditioning 
are stimulated by concern that the astronaut’s performance capabilities 
may be impaired durirg increased gravitational stress following prolonged 
confinement. Consequently, it seemed eminently desirable to assess sensori- 
motor performance both before and after passive tilt and to establish 
whether an increased impairment of performance was exhibitied following 
a period of prolonged inactivity. However, normal performance can be 
maintained or improved under conditions of stress due to activation of 
physiological and psychological compensatory mechanisms. Thus, it be- 
comes necessary to note those aspects of performance which maintain 
stability in addition to those which are impaired when a marked change 
in cardiovascular functioning is observed. 
Four performance variables were administered during the 
second and third bedrest periods. During the second bedrest period, a 
fifth variable was included. Control levels of performance were obtained 
before, during, and after each bedrest period for comparison with observa- 
tions obtained immediately before and after each complex tilt procedure. 
The performance tasks listed below were administered for a total of seven 
occasions for each of the two bedrest conditions. 
11.1.3.1 React ion Time. The latency of a motor response immedi- 
ately follov,Gng a change in physiological functioning provoked by 
passive body tilt was analyzed for comparability with speed of response 
under normal conditions. Changes were expected as a function of this 
condition, particularly when preceded by a period of bed recumbency. 
Mean reaction time was assessed, disregarding length of 
foreperiods which were randomly presented to eliminate establishment 
of a rhythmical response pattern. Six foreperiods ( the interval between 
the ready signal and the presentation of the visual stimulus ) were pre- 
sented during each trial, with four replications per trial. The foreperiods 
were assessed for optimal interval and maintenance of readiness to respond. 
Studies suggest that the temporal growth and decay ofreadiness to res- 
pond may be a paradigm for impairment of broader adjustive capacities. 
This dimension of simple reaction time will be analyzed for change cor- 
relating with a change in physiological functioning under two conditions: 
a) prolonged recumbency, and b) the complex tilt procedure. (See 
test 11.2.14) 
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11.1.3.2 Number Facility. Possible changes in intellectual func- 
tioning was assessed by a task involving the addition of 1 and 2 digit 
numbers in sets of three. Interpretations based on factor analysis sug- 
gest the test represents an undifferentiated retentiveness and freedom from 
distractibility, which may be subject to change as a function of altera- 
tion of physiological functioning. (See test 11.2.15) 
11.1.3.3 Speed of Closure. Speed of perception and discrimina- 
tion was assessed by a task requiring selection of common English four- 
letter words from a heterogenous stimulus grouping-letters of the alpha- 
bet spaced at equidistant intervals -in which were imbedded additional 
four-letter words ( proper nouns, foreign words, plural words ), two- 
three-, and five-letter words. Factor analytic studies have reported this 
test to be a measure of the capacity to resist distraction as well as the 
capacity to organize discrete spatially perceived units into large con- 
figurations which may be affected by altered physiological changes which 
would influence performance on subsequent psychometric measures. (See 
test 11.2.16) 
11.1.3.4 Visualization. The task, visual tracking of intersecting 
lines, was included to assess any blurring of vision resulting from physio- 
logical changes which would influence performance on subsequent psycho- 
metric measures. (See test 11.2.17) 
11.1.3.5 Aiming. The test requires precise visual-motor coordina- -- 
tion-placement of a stylus point in a sequence of specified locations. 
Delay in attaining homeostatic equilibrium after exposure to physiologi- 
cal stress may be manifested by inability to perform exacting tasks. 
Variables 2 through 5 were assessed for number attempted 
and errors of commission. Th ese two dimensions of each variable were 
treated as separate variables in all analyses, thus providing a total of 
nine performance measures. Previous investigations report an increase in 
errors and in speed under conditions of physiological stress. (See test 
11.2.18) 
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FOCUS THEMATIC APPERCEPTION’ 
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GUILFORD - ZIMMERMAN PERSONALITY INVENTORY 
Read each statement carefully. If the statement seems 
to be true or if you agree with it, mark answer “yes”. If the statement 
is more false than true, or if you disagree with it, mark “no”. 
Be sure to answer every item. 
Although each item should be read carefully, it is best 
not to spend excessive time thinking over a statement. Work fairly rapidly 
and answer with your first impression. 
This is not a test; there are no right or wrong answers. 
The purpose of this survey will be best served if you describe yourself and 
state your opinions as accurately as possible. 
Yes No 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
Il. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
You stort to work on a new project with a great deal of 
enthusiasm. 
When you eat a meal with others, you are usually one of 
the last to finish. 
You are happiest when you get involved in some project 
that calls for rapid action. 
You are often so much “on the go” that sooner or later 
you may wear yourself out. 
You often wonder where others get all the excess energy 
they seem to have. 
You find yourself hurrying to get places even when there 
is plenty of time. 
You work more slowly and deliberately than most people 
of your sex and age. 
You like to have plenty of time to stop and rest. 
You are the kind of person who is “on the go” all the time. 
People think you are a very energetic person. 
You are quick in your actions. 
You always seem to have plenty of vigor and vitality. 
You sometimes wish that people would slow down a bit and 
give you a chance to catch up. 
You seem to lack the drive necessary to get as much done as 
other people do. . 
You are able to work for unusually long hours without feel- 
ing tired. 
You talk more slowly than most people. 
You like to do things slowly and deliberately. 
You are inclined to rush from one activity to another with- 
out pausing enough for rest. 
You are less energetic than many people you know. 
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20. You get things done in a hurry. -- 
21. At work or at play other people find it hard to keep up 
with the pace you set. 
- -22. You dislike to be hurried in your work. 
- -23. People sometimes tell you to “slow down” or “take it easy.” 
-24. You are slow and deliberate in movement. 
-25. You can turn out a large amount of work in a short time. 
-26. You often run upstairs taking two steps at a time. -- 
27. Others are often amazed by the amount of work you turn out. -- 
28. It irritates you to have to wait at a crossing for a long 
freight train to pass. 
- -29. Other people regard you as a lively individual. 
-30. It is hard to understand why many people are so slow and 
get so little done. 
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KINESTHETIC AFTER EFFECTS 
SENSITIVITY 
PROCEDURE: 
1. BI indfold subject. 
2. Place subiect’s hands on the two stimuli, instructing him to 
lightly rule graduated variable stimulus and square stan- 
dard stimulus simultaneously. Obtain size estimate 
from variable stimulus for baseline measure. 
3. Repeat Step 2 to obtain pre-satiation size estimate. 
4. Instruct the subject to rub large satiator block 90 seconds 
to produce satiation size estimate. 
After 5ninute rest interval, repeat entire procedure. 
TRIAL 1 
Base 
Pre-satiation 
TRIAL 2 
Post-satiation 
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Good-natured 
Troubled 
Efficiant 
Dependable 
Clearthinking 
Lonely 
Humorous 
Rude 
Kind 
Daring 
Considerate 
Boastful 
Dcf iant 
Fatigued 
Unhappy 
Businesslike 
Friendly 
Grouchy 
Sleepy 
Sad 
Bossy 
Impulsive 
Jlttcry 
Bold 
A Quite 
little a bit Extremely 
0 
I 
0 
Playful 
Afraid 
Able to York Hard 
Yarn-hearted 
Sick to the Stomach 
Alert 
Tired 
Shaky 
Demanding 
Sociable 
Nagsing 
Sarcastic 
Pleasant 
Quarrelsome 
Independent 
Depressed 
Drormy 
Able to Concentrate 
Dizzy 
Reckless 
Downhearted 
Korried 
Porceful 
Polite 
Not 
at all 
iI 
A Quito 
little a bit 
BEHAVIOR RATINGS 
SUBJECTS NAME 
RATER” S NAME 
HIGH AROUSAL 
Restless 
Tense 
Jittery 
Agitated 
DATE 
TIME 
SOCIABLE 
Conversational 
Gregarious 
Mixing 
Companionable 
UNPLEASANT 
Unhappy 
Gloomy 
Down-hearted 
POSITIVE ATT. 
Agreeable 
Patient 
Easy to please 
LOW AROUSAL 
Relaxed 
Drowsy 
Sluggish 
Listless 
UNSOCIABLE 
Quiet 
Reserved 
Aloof 
Seclusive 
PLEASANT 
Cheerful 
Gay 
HIPPY 
NEGATIVE ATT. 
Complaining 
Irritable 
Hard to please 
Sarcastic 
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TWO POINT DISCRIMINATION 
NAME DATE - TIME 
Series 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Direction Magnitude 
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NECKER CUBE 
NAME DATE TIME 
Trial No. of Reversals No. of Blinks 
1 
2 
3 
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PERCEPTUAL SPEED 
(PS) 
PERCEPTUAL SPEED 
Look at the rows of numbers below. A ring has been put around the first 
number in each row. The numbers in the row that are like the circled number 
are crossed out. 
. 
Cross out the numbers in the following rowa that are like the circled numbera 
at the beginning of each row. 
019523 
a67158 
095482 
045352 
Here are more practice rows. Cross out each number in a row that ir like the 
circled number at the beginning of each row. 
0 87603521058479326585380118 
0 
25910794200834208616935861 
0 
55825973468532019674567243 
0 
53580181074257587432790187 
0 
45369122537580386053421975 
0 38347182027436801863647965 
0 74585745873268459110784276 
0 
96454758018325457968017539 
0 
10795334791704023758153790 
When the signal ir given (not yet), turn the page and cross out each number in 
a row that is like the circled number. Work Fast. Find as many numbers as 
you can in the time allowed. 
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PS-Form 1La Cross out each number in a row that IS like the circled number. 
0 L17686584689413923586022L5151 
a 93627694613799337553977327709 
0 6772302770961872521280625049i 
c9 32828260873373204056930169005 
a 84376716120449032649767639961 
@ 32253643907106376358703047988 
@ 19648950307163933669856105679 
0 87658547492387096925206797945 
0 36835260099539361285270054834 
a 53924709993865277641533590528 
0 87196302418462334278513992344 
0 85086544822064372528221156520 
0 73527337224536394094110764791 
0 69389412629708363519974205236 
0 88700423157901202072347371731 
c9 85653275933357267477734554570 
@ 97295842949412106704238064518 
0 29688173165196902836074869068 
@ 59457241692099438762200276995 
0 86443599898779768079151786244 
0 34409427200418679796847220020 
c9 07666268457999039736633208458 
@ 21779180512595257022207904703 
8 51782 065331511096469206880777 
@ jiOl2 429296118344803468354877 
Subject Dote Examiner-.- 
c”..s*l .I le.” I.LU,.” I” m.m.1 *..111, I,,, 
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WORD FLUENCY 
Six letters of the alphabet- E, C, G, H, I, L - were presented 
to each subject during one bedrest period. The order of presentation was 
randomized for each subiect. Responses to two letters were obtained for 
each of three trials administered during one bedrest period. 
The following instructions were given: Two letters of the alpha- 
bet will be presented sequentially. Name as many words as pos- 
sible which begin with letter presented when the signal to begin 
is given. Each trial will be one minute in duration, with a 
30-second interval between the two trials. 
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HOI.lZMAN INKBLOT TKCHNIQUK FrrA 
RCCORD CDRY 
>“C -chant in card pniticm; R.T. -rration time in semndsll. 
UT. - 
RT. - 
IA R.T. - 
3h 
99 
Appendix 11.2.11 (Cont’d) 
IA R.T. - 
sh RT. - 
/ \. ../ - 
Oh RT. - 
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1.1. - 
a 
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w LT. - 
'A LT. - 
102 
II - 
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LT. - 
LT. - 
103 
yigp .- _ . .._.. ~ 
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IO.4 R.T. - 
IIA LT. - 
IA R.T. - 
IA ET. - 
V V 
@% 
. 
- 
I - 
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I II.T. - 
R RT. __ 
m LT. - 
B R.T. - 
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ID LT. - 
Q-9 
a 
0 
P LT. - 
.- 
----I 
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n \LT. - 
BIB RT. - 
110 
I 
- 
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m LT. - 
m *- 
1 )(I LT. - 
n LT. - 
n LT. - 
7B LT. - 
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Y UT. - 
1 
LT. - 
R.T. - 
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mJYy*RY S”lRT HOLTZMAN INKBLOT TKCHNIQUE Form: Grcb) A I) 
so. I HT I ” I ‘ I s 1 FDIFAIC IShIM 1 \’ II IH iA iAtiSxlAbI1C1I It*ISrit’IIIRI pi 1 
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,, rlwr .vL rd.,,. 6, I,,-,,,. , 2: I l,,,,, Is,- e,.,, ,111 ,111 s or,, 
_________-_-------------------------------------------~ 
2h 
29 
40 
A. I I I I I I I I I I I I I I I 
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ATTENTIONAL ORIENTATION 
NAME DATE 
1. 
3 -. 
3. 
4. 
5. 
6. 
7. 
8. 
0 I . 
10. 
11. 
12. 
13. 
i4. 
15. 
16. 
17. 
18. 
19. 
20. 
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SUBJECT QUESTIONNAIRE 
Name: 
Date: 
Instruct ions ------- 
We wish to learn as much as possible about your experiences 
during the period in which you were immobilized. To help us do this, we 
will ask you to consider each of the stotements below and indicate how it 
applies to you. Notice that to the left of each statement there are three 
columns: the first one is marked NEVER, the second ONCE or OCCASION- 
ALLY, and the third FREQUENTLY. Put a check in the space under NEVER 
beside each statement that did not apply to you even once during the time - 
you spent in this experiment. Put a check in the space under ONCE or 
OCCASIONALLY beside each statement that refers to experiences you had 
once or a few times during your time in the experiment. Put a check in the 
space under FREQUENTLY b esr ‘d e each statement that refers to things you 
experienced more than a few times or that was generally true about experi- 
ences during the experiment. 
Many of these statements refer to very personal experience, 
but we assure you that your answers will be kept in utmost confidence, and 
they will be very useful to us in studying your reactions and experiences 
while participating in this experiment. So please consider each statement 
very carefully and mark it so that it will be a true statement about you 
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during the ten days of immobilization, excluding the tilting procedure. 
Please do not fail to answer every statement. 
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--- 
--- 
--- 
--- 
--- 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
I was hungry. 
I was kind of mad. 
My feet and/or my hands were cold. 
I remembered plesant times I had had with a girl 
or my wife. 
I worried about something that really did not matter.’ 
I thought about food. 
I was very hungry. 
I felt as angry as I coJd get. 
I felt as though no one really cared about me 
as a person. 
I had dreams about food. 
I did not feel fresh and rested when I woke up. 
It was hard to keep my mind on one thing. 
I thought the personnel in the experiment were taking 
advantage of me. 
felt a desire for some particular kind of food. 
felt tense. 
had diarrhea. 
wished I could talk to people I was unable to talk to. 
was constipated . 
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19. I -- 
20. I - -- 
21. I - -- 
22. I - -- 
23. I - -- 
24. I - -- 
thought about my health. 
had unusual dreams. 
thought about the injustices people have to put 25. I - -- . up with. 
felt 
had 
had 
felt 
a great desire for some particular food. 
nightmares. 
difficulty keeping warm enough. 
depressed. 
26. - -- 
27. - -- 
28. - -- 
29. - -- 
30. - -- 
31. - -- 
32. - -- 
33. - -- 
34. - -- 
35. - -- 
36. - -- 
37. - -- 
38. - -- 
I felt so restless I could not keep from moving around. 
I could relax and not worry about anything. 
I wanted to be able to be following my normal routine. 
I thought the experimenters were wasting their time. 
I felt the world was a pretty nice place to be in. 
I found something entertaining to do. 
I thought about sex. 
My sleep was restless and disturbed. 
I wondered why I volunteered for this experiment. 
My head ached. 
I had difficulty keeping cool enough. 
I felt suddenly hot all over, without apparent cause. 
I prayed. 
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x = 
E g 
k 
“0 .; tl 
3 u”B z- 
Z 66 LE 
39. I felt hopeful about the future. 
- -- 
40. I regretted having volunteered for this experiment. 
- -- 
41. I felt physically comfortable. 
- -- 
42. I gained some reasurrance from praying. - -- 
43. I was annoyed by the noises in the room. 
- -- 
44. I felt I was wasting my time. 
- -- 
45. I thought it would be nice to take part in more 
- -- 
experiments. 
46. I felt like a fool. 
- -- 
47. I tried to understand just what it was the experimen- 
- -- 
ters were interested in finding out. 
48. I was able to think clearly about something that had 
- -- 
bothered me for some time. 
49. I had pains in my back or shoulders. 
- -- 
50. I was unhappier than I was at any time in the past. 
- -- 
51. Some of the things I had to do in the experiment 
- -- 
were very pleasurable. 
52. I could not keep my mind on one thing. - -- 
53. I had dreams that were very upsetting. 
- -- 
54. I worried about my health. 
- -- 
55. I had unusual daydreams. 
- -- 
56. I was sweaty when I woke up. - -- 
57. I felt some discomfort in my legs. - -- 
122 
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58. I made plans for the future. -e- 
59. I was easily angered. --P 
60. Some muscles became stiff. -- 
61. I wanted to sleep. -- 
62. I could not rest comfortably because of annoying -- 
sensations in my body. 
63. I felt discouraged. -- 
64. I felt some envy for the fellows who did not volun- -- 
teer for this experiment. 
65. I was discouraged by not being able to take any -- 
action on things I thought about. 
66. I felt unusually happy. -- 
67. I had a twitching or jumping muscle. -- 
68. I had some discomfort over my heart or in my chest. -- 
69. I felt a peculiar sensation in some part of my body. -- 
70. Parts of my body had feelings like “going to sleep.” -- 
71. My head felt enlarged. -- 
72. I had dreams which were strikingly vivid. --- 
73. I felt a nervousness I can’t explain very well. -- 
74. I had daydreams that I could not get out of my mind. -- 
75. I felt as though some part of my body had changed --- 
in size. 
76. I dreamt when I slept. -- 
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77. I felt unhappy. -- 
78. Some of my dreams were repeated. --- 
79. I felt light-headed. --- 
80. I felt like fighting with someone. -- 
81. I looked forward to the tests that were given. --- 
82. I felt as though I needed a real bath. -- 
83. I ran out of things to think about. -- 
84. I found it difficult to remember clearly what I was -- 
thinking about only a short time earlier. 
85. My ability to concentrate was worse than usual. --- 
86. I could remember distant events and experiences --- 
much better than normally. 
87. My thoughts were iumbled. -- 
88. My ability to reason and engage in constructive --- 
thinking was better than usual. 
89. My thoughts moved faster than usual. --- 
90. My thoughts moved slower than usual. --- 
91. My judgment and ability to evaluate were worse --- 
than usual. 
92. My mind was a blank at times, so that I had no -- 
thoughts at all. 
93. At certain times thinking and reflecting seemed --- 
too much of an effort. 
94. My body felt strange in some way. --P 
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95. At times I daydreamed about sexual matters. -- 
96. I had very strange daydreams. -- 
97. I could not rest comfortably because of annoying -- 
sensations in my body. 
98. I was quite restless. -- 
99. I started to sweat for no reason at all. -- 
100. I was physically uncomfortable. - -- 
101. I found my experience stressful. -- 
102. I experienced tingling sensations in my body. -- 
103. l was more preoccupied with sex than usual. -- 
104. I felt lonely. -- 
105. At times I had to assure myself that I was all right. -- 
106. I was irritable a lot of the time. -- 
107. I felt depressed or sad. -- 
108. I felt especially happy. -- 
109. I was afraid or upset. -- 
110. I felt angry or annoyed. -- 
11 1. I sometimes lost control over my emotions and feelings. --- 
112. At certain times I experienced a.state of serenity, --P 
peacefulness and an attitude of “all’s well with the 
world. ” 
113. Time seemed to stand still. --- 
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114. --- 
115. --- 
116. --- 
117. --- 
118. --- 
--- 
--- 
--- 
--- 
-.-P 
--- 
119. --- 
120. --- 
121. --- 
I felt that I occasionally lost sense of time. 
Time passed faster than usual. 
Time passed slower than usual. 
I felt that time had come to a standstill. 
I experienced the following physical sensations 
during the immobilization period: 
(4 
b) 
(c) 
(4 
(e) 
(f) 
(d 
04 
(3 
(9 
M 
dizziness 
numbness or tingling 
chills or a cold feeling 
felt hot or sweating 
funny taste in my mouth 
felt nauseous or sick at the stomach 
mouth dry or less saliva than usual 
pressure or ringing in ears 
felt weak physically 
body felt lighter or like it was floating in space 
body felt heavier 
I was very anxious about the catheterization proce- 
dure, 
I became personally involved in what the other sub- 
jects were doing and thinking. 
I looked forward to getting back to my normal eating 
habits. 
126 
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122. l wished I had selected a different bed position. 
123. l was very anxious about receiving injections. 
124. I wanted to have more visitors. 
125. 
126. --- 
127. -- 
128. -- 
129. --- 
130. --- 
131. -- 
132. --_c 
133. --- 
134. -- 
135. --- 
136. -- 
137. --- 
138. --- 
139. 
--- 
-- 140,. 
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I felt the routine of the experiment became 
terribly monotonous. 
l felt I was being treated as an experimental animal. 
I was irritated by the psychological tests. 
I missed having people around with whom I could 
discuss ideas which interested me. 
I found myself worrying about how I would hold up 
on the tilt test. 
I felt the experiment was a pleasant change from 
my usual activities. 
I wanted to be able to devote more time to concen- 
trated reading and study. 
I became annoyed with some of the other subiects. 
I felt the expeimenters did not do all they could 
to make our surroundings comfortable. 
I felt that life was passing me by. 
I wished the other subjects could be quiet. 
l felt I couldn’t go on with the experiment. 
I felt extremely bored. 
I enjoyed the company of other subiects. 
I got fed up with the experiment. 
I wished I had something better to do to pass the 
time. 
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REACTION TIME 
NAME DATE TIME 
TRIAL FOREPERIOD LATENCY SUMS 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
2 ss 2 
4 ss 4 
6 SS 6 
8 SS 8 
10 ss 10 
I2 ss 12 
Total SS 
x R. T. 
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@iF-Form 14 r”w* ., *m .-a... I. 1*.4.1 n..Ilh I.,. 
NUMBER FACILITY 
55 43 18 
, ‘Bf , , ::, , 2, 
85 a9 36 
43 22 37 
42 25 9 
27 27 92 16 78 78 
66 7 18 24 37 6 
43 74 53 90 21 20 
16 
2 
65 
I 
49 
4 
53 
36 
48 
60 
I 
99 
16 
79 
1 63 93 6 89 
91 56 30 29 57 
34 66 3 13 87 
50 16 
68 
54 4 
& 
16 55 
22 59 
77 56 
15 
27 
98 
I 
12 
56 
85 
83 62 36 
26 45 27 
53 72 45 
74 20 7 
, E, , ::, , t:, 
57 33 63 
60 21 1 
86 12 63 
I III 
84 
42 
17 
I 
53 
31 
57 
16 97 3 
76 74 47 
62 24 43 
32 34 78 
44 29 59 
9 78 16 
94 35 99 27 67 73 
39 64 26 66 62 86 
6 54 46 27 71 57 
47 64 95 24 54 54 96 
27 56 55 55 43 82 68 
96 7 50 57 49 38 96 
50 81 
56 42 
7 20 
32 42 
90 53 
96 
47 
36 
I 
61 
46 
98 
I 
63 
71 
62 
54 82 19 
, :‘: , , ::, , ::, 
46 7 50 
9 44 71 
88 82 21 31 
77 17 31 5 
4 37 62 3 
93 43 72 
23 90 93 
74 
47 
67 
79 32 
78 37 
53 32 fltifl fl fl Lfl El IJO 
90 I5 12 21 87 6 57 13 27 33 
52 51 86 76 35 18 12 55 7 26 
, 84 , , 36, I 7;, I 3;, , LO1 , 44, , 10, , 38, , 36, , 16, 
Subject E-mine r Date- 
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SPEED OF CLOSURE 
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VISUALIZATION 
V-Form 5 Follow l och line with your l ycr to its proper coll on the right ond 
writ. the numbor of the line in the cell. 
Subioct Dote Examiner 
Cr..,*8 ,, lw” V..“W,.” I.. I..‘.’ q ,. s. I*,. 
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A-Form 1 
AIMING 
Put 0 dot entirely inside each circle. 
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PSYCHOLOGICAL TESTS SCHEDULE 
- -DATE SUBJECT NUMBER TESTS 
6-8-64 
6-13-64 
6-14-64 
6-15-64 
6-16-64 
6-17-64 
6-18-64 
6-19-64 
6-20-64 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10 16 PF, GA, FTT; KAE 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10 PS, WF, TPD, RC 
HIT 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10 TPD, RC 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10 AO, *CMS, ?BR 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10 CMS, BR 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10 CMS, BR 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10 CMS, BR 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10 CMS, BR 
1, 2, 3, 4, 5............... HIT, RC 
6-21-64 I, 2, 3, 4, 5, 6, 7, 8, 9, 10 CMS, BR 
6, 7, 8, 9, lo.............. HIT, RC 
6-22-64 
6-23-64 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10 AO, CMS, BR 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10 CMS, BR 
1, 2, 3, 4, 5............... PS, WF, TPD 
6-24-64 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 CMS, BR 
6, 7, 8, 9, 10 . . . . . . . . . . . . . . PS, WF, TPD 
6-25-64 
6-26-64 
6-27-64 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10 HIT, RC, CMS, BR 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10 CMS, BR 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10 AO, CMS, BR 
1, 2, 3, 4, 5............... PS, WF, TPD 
6-28-64 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 CMS, BR 
6, 7, 8, 9, 10 . . . . . . . . . a . . . . PS, WF, TPD 
1, 2, 3, 4, 5.. . . . . . . . . . . . . . HIT, RC 
6-29-64 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 CMS, BR 
6; 7, 8, 9, lo.............. HIT, RC 
6-30-64 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 CMS, BR, R 
--L% -. - _... ---... --.-.. .--._ 
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PSYCHOLOGICAL TESTS SCHEDULE 
7-l-64 
7-2-64 
7-3-64 
7- 16-64 
7-20-64 
1, 2, 3, 4, 5, 6, 7, a, 9, 10 CMS, BR, A0 
1, 2, 3, 4, 5, 6, 7, a, 9, 10 CMS, BR 
1, 2, 3, 4, 5, 6, 7, a, 9, 10 CMS, BR, IQ 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 RT, V, NF, A 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 HIT, RC, CMS, BR, RT, V 
NF, ASC, TP 
7-22-64 1, 2, 3, 4, 5.. . . . . . . . . . . . . . RT, V, NF, A,SC, CMS, BR 
7-23-64 1, 2, 3, 4, 5, 6, 7, 9, 10, 11 
1, 2, 3, 4, 5.. . . . . . . . . . . . . . 
6, 7, 9, 10, ll............. 
CMS, BR 
RT, V, NF, A,SC(Pre-Post Tilt) 
RT, V, NF, A,SC 
7-24-64 
7-25-64 
7-26-64 
7-27-64 
7-28-64 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 
6, 7, 9, ll.... . . . . . . . . . . . . . 
CMS, BR 
RT, V, NF, A, SC(Pre-Post Tilt) 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 
1, 2, 3, 4, 5.. . . . . . . . . . . . . . 
CMS, BR 
HIT, RC (CMS, BR) 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 CMS, BR 
6, 7, 9, 10, Il............. HIT, RC (CMS, BR) 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 
1, 2, 3, 4, 5.. . . . . . . . . . . . . . 
AO, CMS, BR 
RT, V, NF, A,SC 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 CMS, BR 
6, 7, 9, 10, ll............. RT, V, NF, A,SC 
1, 2, 3, 4, 5.. . . . . . . . . . . . . . PS, WF, TPD, TP 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 CMS, BR 
6, 7, 9, 10, ll............. PS, WF, TPD, TP 
1, 2, 3, 4, 5.. . . . . . . . . . . . . . HIT, RC 
7-29-64 
7-30-64 
7-3 l-64 
a-1-64 
8-2-64 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 CMS, BR 
6, 7, 9, 10, ll..., . . . . . . . . . HIT, RC 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 CMS, BR 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 CMS, BR 
1, 2, 3, 4, 5... . . . . . . . . . . . . PS, WF, TPD, TP 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 CMS, BR 
6, 7, 9, 10, ll........... 0. PS, WF, TPD, TP 
1, 2, 3, 4, 5.. . . . . . . . . . . . . . HIT, RC 
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PSYCHOLOGICAL TESTS SCHEDULE 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 
6,7, 9, 10, ll... . . . . . . . . . . . 
1, 2, 3, 4, 5 . . . . D . . . . . . . . . . . 
AO, CMS, BR 
HIT, RC 
RT, NF, V, A, SC(Pre 
and Post Tilt) 
8-3-64 
8-4-64 
8-5-64 
8-6-64 
8-7-64 
a-24-64 
a-25-64 
8-26-64 
a-27-64 
a-28-64 
a-29-64 
a-30-64 
a-31 -64 
9-l -64 
9-2-64 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 
6, 7, 9, 10, ll............. o 
CMS, BR 
RT, NF, V, A, SC(Pre 
and Post Tilt) 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 CMS, BR, R 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 RT, NF, V, A, SC, CMS, BR 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 AO, IQ, CM, BR 
1, 2, 3,4,5,6,7, 9, 10, 11 HIT, RC, CMS, BR 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 AO, PS, WF, TP, CMS, BR 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 RT, NF, V, SC, CMS, BR 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 
1 I 2, 3, 4, 5 . . . . . . . . . . . . . . . 
CMS, BR 
RT, NF, V, SC (Pre and 
Post Tilt) 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 
6, 7, 9, 10, ll.......,..... 
CMS, BR 
RT, NF, V, SC (Pre and 
Post Tilt) 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 
1 r 2, 3, 4, 5 . . . . . . . ..e..... 
CMS, BR 
HIT, RC 
1, 2, 3,4,5,6,7, 9, 10,ll 
6, 7, 9, 10, ll,....,....... 
CMS, BR 
HIT, RC 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 
1, 2, 3, 4, 5.. . . . . 000.000.. 
AO, CMS, BR 
RT, NF, V, SC 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 
6, 7, 9, 10, ll...... . . . . 0.. 
1 I 2, 3, 4, 5 . . . ..-......a.. 
CMS, BR 
RT, NF; V, SC 
PS, WF, TP 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11 
6, 7, 9, 10, 11. . . . . . . . . . . . . 
1, 2, 3, 4, 5...... . . . . . 0... 
CMS, BR 
PS, WF, TP 
HIT, RC 
9-3-64 1, 2, 3, 4, 5, 6, 7, 9, 10, 11 
6, 7, 9, 10, 11. . . . . e.e..ee. 
CMS, BR 
HIT, RC 
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PSYCHOLOGICAL TESTS SCHEDULE 
9-4-64 1, 2, 3, 4, 5, 6, 7, 9, 10, 11 CMS, BR 
9-5-64 1, 2, 3, 4, 5, 6, 7, 9, 10, 11 CMS, BR 
1, 2;3, 4, 5 . . . . . . . . . . . . . . . PS, WF, TP 
9-6-64 1, 2, 3, 4, 5, 6, 7, 9, 10, 11 AO, CMS, BR 
6, 7, 9, 10, ll............. PS, WF, TP 
1, 2, 3, 4, 5 . . . . . . * . . . . . . . . HIT, RC 
9-7-64 1, 2, 3, 4, 5, 6, 7, 9, 10, 11 CMS, BR 
6, 7, 9, 10, ll............. HIT, RC 
1, 2, 3, 4, 5.. . . . . . . . . . . . . . RT, NF, V, SC (Pre & 
Post Tilt) 
9-8-64 1, 2, 3, 4, 5, 6, 7, 9, 10, 11 CMS, BR 
6, 7, 9, 10, 11 . . . . . . . . . . . . . RT, NF, V, SC (Pre & 
Post Tilt) 
9-9-64 1, 2, 3, 4, 5, 6, 7, 9, 10, 11 CMS, BR, R 
9-10-64 1, 2, 3, 4, 5, 6, 7, 9, 10, 11 AO, RT, NF, V, SC, 
CMS, BR 
9-l l-64 1, 2, 3, 4, 5, 6, 7, 9, 10, 11 IQ,CMS, BR 
*Administered AM and PM 
A Aiming 
A0 Attentional Orientation 
BR Behavior Ratings 
CMS Clyde Mood Scale 
FTT Focused Thematic Test 
GA Guilford’s Temperament Survey, Activity Dimension 
HIT Holtzman Inkblot Test 
IQ Immobilization Questionnaire 
KAE Kinesthetic After-effects 
NF Number Facility 
PS Perceptual Speed 
R Rankings 
RT Reaction Time 
16PF Cattell’s Sixteen Personality Factor Inventory 
SC Speed of Closure 
TP Time Perception 
TPD Two-point Discrimination 
V Visualization 
WF Word Fluency 
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12. TILT STUDIES 
TILT SCHEDULE 
SUBJECT TILT TYPE OF 
DATE TIME NUMBER NUMBER TILT 
6- 14-64 7:00 1 1 * 
a:00 
9:oo 
1o:oo 
11 :oo 
12:oo 
13:30 
14:30 
17:30 
la:30 10 1 * 
6- 16-64 7:oo 1 2 * 
a:00 2 2 * 
9:oo 3 2 * 
1o:oo 4 2 * 
11 :oo 5 2 * 
12:oo 6 2 * 
13:30 7 2 * 
14:30 a 2 * 
15:30 9 2 * 
16:30 10 2 * 
6-l a-64 7:oo 1 3 ** 
9:oo 2 3 ** 
1l:OO 3 3 ** 
13:oo 4 3 ** 
15:oo 5 3 ** 
6-l 9-64 7:oo 6 3 ** 
9:oo 7 3 e-k 
11 :oo a 3 ** 
13:oo 9 3 ** 
15:oo 10 3 ** 
6-29-64 7:oo 1 4 ** 
9:oo 2 4 ** 
11 :oo 3 4 ** 
13:oo 4 4 ** 
15:oo 5 4 ** 
6-30-64 7:oo 6 4 ** 
9:oo 7 4 ** 
11 :oo a 4 ** 
13:oo 9 4 ** 
15:oo 10 4 ** 
*Simple - ECG & Cuff ‘Microphone Blood Pressure Measurements. 
**Complete - Vectorcardiogram, Arterial Blood Pressure, Venous Pressure, 
Forearm and Leg Plethysmography, Abdominal EMG, Impedance Pneumograph 
Plasma Volume, Arterial Blood Saturation, Respiratory Gas Analysis. 
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TILT SCHEDULE Continued 
-_--- - - 
DATE TIME ALJBJECT~YO. TILT NO. TYPE OF TILT 
7-7-64- - 13:oo 1 5 * 
14:oo 
15:oo 
16:OO 
17:oo 
i a:00 
19:oo 
20:oo 
21:oo 
22:oo 10 5 * 
7- 14-64 13:oo 1 6 * 
14:oo 
15:oo 
16:OO 
17:oo 
i a:00 
19:oo 
20:oo 
2l:OO 
22:oo 10 6 * 
7-2 l-64 13:oo 1 7 * 
i 4:OO 
15:oo 
i 6~00 
17:oo 
i a:00 
19:oo 
20:oo 
21:oo 
7-23-64 
22:oo 
7:oo 
10 
1 
2 
3 
4 
5 
6 
7 
a 
9 
10 
1 
2 
3 
4 
5 
7 
a 
a 
a 
a 
a 
a 
a 
a 
a 
a 
9 
9 
9 
9 
9 
* 
** 
7-24-64 
8-3-64 
9:oo 
11 :oo 
13:30 
15:30 
7:oo 
9:oo 
11 :oo 
13:30 
15:30 
7:oo 
9:oo 
11 :oo 
13:30 
15:30 
** 
** 
** 
** 
** 
** 
** 
** 
** 
** 
** 
** 
** 
** 
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TILT SCHEDULE Continued 
--- 
DATE TIME SUBJECT NO. TILT NO. TYPE OF TILT 
7:oo 6 9 ** 
9:oo 7 9 ** 
1l:OO a 9 ** 
13:30 9 9 ** 
15:30 10 9 ** 
a-ii-64 13:oo 1 10 * 
14:oo 2 10 * 
15:oo 3 10 * 
16:OO 4 10 * 
17:oo 5 10 * 
la:00 6 10 * 
19:oo 7 10 * 
20:oo a 10 * 
21:oo 9 10 * 
a-la-64 
14:oo 2 11 
15:oo 3 11 
16:OO 4 11 
17:oo 5 11 
la:00 6 11 
19:oo 7 11 
20:oo a 11 
21:oo 9 11 
22:oo 10 11 * 
8-25-64 13:oo 1 12 * 
8-27-64 
14:oo 
15:oo 
16:OO 
17:oo 
la:00 
19:oo 
20:oo 
2l:OO 
22:oo 
7:oo 
9:oo 
1l:OO 
13:30 
2 
3 
4 
5 
6 
7 
a 
9 
10 
1 
2 
3 
4 
12 * 
12 * 
12 * 
12 * 
12 * 
12 * 
12 * 
12 * 
12 * 
13 ** 
13 ** 
13 ** 
13 ** 
15:30 5 13 xx 
a-28-64 7:oo 6 13 ** 
9:oo 
1l:oo 
13:38 
7 
a 
9 
13 ** 
13 ** 
13 ** 
15:30 10 13 *** 
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TILT SCHEDULE Continued 
DATE 
9-7-64 
9-8-64 
9-11-64 
TIME SUBJECTNO. TILT NO. TYPE OF TILT 
7:00 1 14 ** 
9:00 2 14 ** 
1l:OO 3 14 ** 
13:30 4 14 ** 
15:30 5 14 ** 
7:oo 6 14 ** 
9:00 7 14 ** 
11:oo a 14 ** 
13:30 9 14 ** 
i5:30 10 14 ** 
13:OO 1 15 * 
14:oo 2 15 * 
15:oo 3 15 * 
16:OO 4 15 * 
17:oo 5 15 * 
iam 6 15 * 
19:oo 7 15 * 
20:O0 a 15 * 
21:oo 9 15 * 
22:00 10 15 * 
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TECHNIQUE FOR THE DETERMINATION OF FOREARM BLOOD FLOW, 
VASCULAR RESISTANCE AND VENOMOTOR TONE 
Measurements of forearm blood flow, venomotor tone, and 
peripheral vascular resistance were determined as follows. Forearm cir- 
cumference change to venous occlusion was determined by the method of 
Whitney which used a mercury-in-rubber strain gauge. Venous pressure 
was measured through a polyethylene catheter passed into a large forearm 
vein such that the tip of the catheter was located approximately 1 centi- 
meter distal to the mercury-in-rubber gauge. Mean arterial blood pressure 
was obtained continuously from a needle in brachial artery of the opposite 
arm. From the simultaneous measurement of the forearm plethysmograph, 
mean arterial blood pressure, and venous pressure in response to venous 
occlusion, calculation of forearm blood flow, forearm vascular resistance 
and venomotor tone were made. 
Two complete determinations were made at least five minutes 
apart prior to the tilt. Measurements were repeated at one minute, two min- 
utes, four minutes, six minutes, eight minutes, ten minutes, fourteen minutes 
and eighteen minutes of the 70° head-up tilt. Since the position of the arm 
was not changed during the tilt procedure, venomotor tone measurements were 
not thought to be valid during the tilt because of the effect of venous stasis 
on pressure volume relationships. Determinations of venomotor tone measure- 
ments were made immediately after tilting down and at two minutes, four minutes, 
and eight minutes after the tilt-down procedure. 
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CLINICAL OBSERVATIONS RECORD 
TILT OBSERVATIONS 
DATE 
SUBJECT OBSERVER 
I 
I 
EECO CODE EXPERIMENTAL 
HR MIN 1 SEC I CIRCUMSTANCE I OBSERVATION 
I 
I I I 
I 
CODE: Pallor P Sweating SW Barrel Vision B 
Syncope Sy Vomiting V Double Vision D 
Nausea N Convulsion C 
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13. BICYCLE ERGOMETER STUDIES 
BICYCLE SCHEDULE 
SUBJECT TEST 
DATE TIME NUMBER NUMBER 
6-9-64 8:30 6 1 
1o:oo 3 1 
11 :oo 10 1 
13:OO 9 1 
6-l O-64 8:30 5 1 
1o:oo 7 1 
6-l l-64 8:30 2 1 
lo:oo 4 1 
11:00 1 1 
6-l 2-64 8:30 8 1 
1o:ca 6 2 
11 :OO 3 2 
6-l 5-64 8:30 1 2 
1O:OO 7 2 
11 :oo 10 2 
6-l 6-64 8:30 2 2 
lo:OO 4 2 
11 :OO 9 2 
6-l 7-64 8:30 5 2 
1o:oo 8 2 
6-29-64 8:30 1 3 
6-30-64 8%) 3 3 
1o:OO 2 3 
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BICYCLE SCHEDULE Continued 
SUB-TEFT TtbT 
DATE TIME NUMBER NUMBER 
7-l-64 8:30 10 3 
1o:OO 7 3 
11:00 5 3 
13:00 6 3 
7~8-64 8:30 2 
1o:OO 3 
t , 
11:OO 4 4 
13:m 5 4 
7-9-64 8:30 1 4 
lo:OO 9 4 
ll:oo 10 4 
7-10-64 8:30 6 4 
1o:OO 7 4 
11:00 8 4 
7-15-64 8:30 2 5 
1o:OO 3 5 
11:OO 4 5 
13:00 5 5 
7-16-64 8:30 1 5 
1o:OO 9 5 
11:OO 10 5 
7-17-64 8:30 6 5 
1o:al 7 5 
11:OO 8 5 
7-22-64 8:30 2 6 
1o:OO 3 6 
11:OO 4 3 00 5 6" 
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BICYCLE SCHEDULE Continued 
SUBJECT TESr 
DATE TIME NUMBER NUMBER 
7-23-64 8:30 1 6 
lo:oo 9 6 
ll:oo 10 6 
7-24-64 8:30 6 6 
lo:OO 7 6 
ll:oo 8 6 
8-3-64 9:30 1 7 
11 :oo 2 7 
12:30 3 7 
8-4-64 8:00 4 7 
9:30 5 7 
11 :oo 6 7 
8-5-64 8:30 7 7 
lo:oo 8 7 
11:OO 9 7 
13:OO 10 7 
8-12-64 8:30 2 8 
lo:oo 3 8 
11:OO 4 8 
13:OO 5 8 
8-13-64 8:30 1 8 
1o:oo 9 8 
11:oo 10 8 
8-14-64 8:30 6 8 
1o:OO 7 8 
11:OO 8 8 
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BICYCLE SCHEDULE Continued 
SUBJECT TEST 
DATE TIME NUMBER NUMBER 
8-19-64 8:30 2 9 
lo:OO 3 9 
11:OO 4 9 
13:OO 5 9 
8-20-64 8:30 1 9 
lo:oo 9 9 
11:00 10 9 
8-21-64 8:30 6 9 
lo:oo 7 9 
ll:oo 8 9 
8-26-64 8:30 2 10 
lo:OO 3 10 
11:00 4 10 
13:oo 5 10 
8-27-64 8~30 1 10 
lo:oo 9 10 
ll:oo 10 10 
8-28-64 8:30 6 10 
1o:OO 7 10 
11:OQ 8 10 
9-7-64 9:30 1 11 
11:00 2 11 
12:30 3 11 
9-8-64 8:00 4 11 
9:30 5 11 
11:oO 6 11 
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BICYCLE SCHEDULE Continued 
SUBJECT TEST 
DATE TIME NlJLAR!I”. NUMBER * -- 
9-9-64 8:30 7 11 
1o:Oa 8 11 
11:OO 9 11 
13:03 10 11 
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PROCEDURE OF THE BICYCLE ERGOMETER STUDIES 
The bicycle ergometer test was performed as follows: Electrodes 
for the recording of the impedance pneumogram and the electrogram were 
placed on the chest of the subject and connected to the respective trans- 
ducers. The signals generated by the transducers were recorded directly 
with a Sanborn recorder on a PI-600 magnetic tape recorder. These recordings 
were taken continuous1 y at rest, during exercise and for 10 minutes after 
cessation of exercise. By visualization of tachometer the rate of pedalling 
was kept at 60 ‘pm. Recordings at rest were taken during 3 minutes. At the 
end of the third minute the subject was instructed to start to pedal the bicycle 
which had been set at a work load of 30 watts. The subject pedalled the 
bicycle at this work load for three minutes, this being used as a warming-up 
period. At the beginning of the seventh and each successive minute there- 
after the work load was increased 10 watts until a heart frequency of 180 
beats was approached. At that moment the subject suddenly ceased working 
but remained seated on the bicycle for ten minutes with the legs flexed and 
the feet on the bicycle box. During this time the electrocardiogram and the 
impedance pneumogram continued to be recorded. Samples of expired air 
were collected in Douglas bags by means of a undirectional Rudolph valve at 
40, 80, 120 watts and at the final minute of exercise, that is, when the heart 
rate reached or approached a frequency of 180. The volume of air contained 
in the Douglas bags was measured with a wet gas meter. The concentrations 
of oxygen and CO2 in the expired air were determined with the Scholander 
apparatus. 
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14. ERKIN STUDIES 
SCHEDULE 
DATE ERKIN PROTOCOL RECORDING UNIT SUBJECTS 
- - 4 Tape 
6-15/16-64 
6- 17-64 
6-l 7/l 8-64 
6-20-64 
6-2 l-64 
6-22-64 
6-23-64 
6-24-64 
6-25-64 
6-26-64 
6-27-64 
6-28-64 
6-28-64 
6-29-64 
6-30-64 
7-l-64 
7-3-64 
7-6-64 
5 
5 
5 
5 
6 
Tape All 
Tape All 
Sanborn All 
Sanborn All 
Sanborn All 
Sanborn All 
Sanborn All 
Sanborn Al I 
Sanborn All 
Sanborn All 
Sanborn All 
Sanborn All 
Tape All 
Sanborn Group Code 2** 
Tape Group Code l* 
Tape Group Code 2** 
Tape All 
Tape All 
7-l o-64 6 Tape All --e-----N--- ----- ---- 
T-G Code 1: 1st bedrest wfcuff; 2nd Gdrest w~~~r~~,~~~6~~~s~~~~e. 
** Group Code 2: 1st bedrest w/exercise, 2nd bedrest w/cuff; 3rd bedrest, none,, 
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Erkin Schedule Continued 
DATE ERKIN PROTOCOL RECORDING UNIT SUBJECTS 
7-l 3-64 5 Sanborn All 
7- 13-64 3 
7- 16-64 3-A 
7-20-64 3 
7-2 l-64 5 
7-22-64 5 
7-23-64 3-A 
7-24-64 5 
7-25-64 5 
7-26-64 5 
7-27-64 5 
7-28-64 5 
7-29-64 5 
7-29-64 6 
7-30-64 6 
7-30-64 5 
7-3 l-64 5 
8-l -64 5 
8-2-64 5 
8-2-64 6 
8-2-64 3 
8-3-64 5 
8-3-64 3 
Tape 
Tape 
Tape 
Tape 
Tape 
Tape 
Tape 
Tape 
Sanborn 
Sanborn 
Sanborn 
Sanborn 
Sanborn 
Tape 
Tape 
Sanborn 
Sanborn 
Sanborn 
Tape 
Tape 
Sanborn 
Tape 
All 
All 
All 
All 
All 
All 
Group Code l* 
All 
All 
All 
All 
All 
Group Code l* 
Group Code 2** 
All 
All 
All 
All 
All 
Grwp Code 1” 
Group Code 2”” 
Group Code 2** 
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Erkin Schedule Continued 
ERKIN PROTOCOI REC 
8-6-64 5 
8-7-64 6 
8-7-64 3 
8-12-64 3 
8-14-64 6 
8-2 l-64 3 
8-24-64 3 
8-24-64 5 
8-25-64 6 
8-26-64 5 
8-26-64 3 
8-27-64 3 
8-28-64 5 
8-29-64 5 
8-20-64 5 
8-3 1-64 5 
9-l-64 5 
9-2-64 5 
9-3-64 5 
9-4-64 5 
9-s-64 5 
9-6-64 5 
9-6-64 3 
Sanborn All 
Tape All 
Tape All 
Tape All 
Tape All 
Tape All 
Tape All 
Sanborn All 
Tape All 
Sanborn All 
Tape Group Code 1* 
Tape Group Code 2** 
Sanborn Grzwp Code 1” 
Sanborn Group Code 2** 
Sanborn Group Code l* 
Sanborn Group Code 2** 
Sanborn Group Code 1* 
Sanborn Group Code 2”* 
Sanborn Group Code l* 
Sanborn Group Code 2** 
Sanborn Group Code 1” 
Sanborn Group Code 2** 
Tape Group Code l* 
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Erkin Schedule Continued 
DATF 
9-/-64 
ERKIN PROTOCOL RFCORDING UNIT S 
3 Tape 
9-8-64 3 
9-9-64 3 
9-9-64 5 
9-l O-64 6 
9- 1 O-64 5 
9-l l-64 3 
9-l l-64 6 
Tape 
Tape 
Sanborn 
Tape 
Sanborn 
Tape 
Tape 
Group Code l’* 
Group Code 2** 
All 
All 
Al I 
All 
All 
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PROCEDURES OF ERKIN TESTS AND EXERCISES 
Erkin I Protocol (Design Measurements): 
This series of tests was designed to provide information on the 
individual’s maximum pulling force at different points in the range of 
motion that was employed using the Bungie exerciser. The subject was 
positioned supine, with feet braced against a footboard. One end of an 
adjustable but nonyielding cable was attached to the footboard and the 
other end was fastened to a bar handle, which was grasped by the subject 
with both hands. A tensiometer was coupled in the cable line to register 
the axial force produced along the cable by the subiect’s pull. Measure- 
ments were taken with the arms in full extension, with the elbows flexed to 
45O, and finally with elbows flexed to 90°. Measurements were taken of 
the distances between the handle and the footboard for each subject in 
each of these positions. These values were used to design the lengths 
and degree of Bungie stretch for each subiect’s exercise dose. 
Erkin II protocol (Standardization Tests): 
This series of tests was designed to standardize in advance the exer- 
cise dose for each subiect. The objective of adjusti ng the exercise dose is to 
avoid severe fatigue while stil I obtaining moderate but not excessive cardio- 
vascular response to the exercise, as measured by the increase in the heart 
rate during the exercises. It was decided to assign arbitrarily an exercise 
dose that would increase the heart rate 40-50 per cent over the resting level 
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in a two-minute exercise of 120 pulls on the Bungie at the rate of one pull 
per second. 
Initially, each subject was given a dose of bungie pulling at 40 
per cent of his maximum in the range of motion terminating at 90’ elbow 
flexion. All subjects used the same length of Bungie rubber, with a varia- 
tion in the length of the coupling cable to the foot piece made according 
to the height of the subiect. The starting point for the pull was determined 
by the magnitude of Bungie stretch at this terminal tension. During this run, 
the ECG was monitored. If this exercise was too severe (i.e., producing 
excessive increase in heart beat rate) the terminal tension was reduced and 
another run was monitored. If the initial exercise was too easy, the terminal 
tension was increased until as desired increase in heart rate was achieved. 
In this manner a standard exercise dose and Bungie setting was determined 
in advance for each subject prior to the first bedrest period. This dose was 
retained for each man for the in-bed conditioning exercises, which was 
designated OS the Erkin V protocol. 
Erkin IV Protocol (Experiment): 
This was an intermediate test for the purpose of identifying the pre- 
ferred time of the precise series and for the purpose of making more precise 
the conditions of Erkin II. 
Erkin VI Protocol (Criterion Test): 
This test was performed with the Bungie exercise and was the same 
as Erkin V except that the ECG was monitored four minutes before exercise 
and five minutes after exercise. The exercise routine was 300 pulls on the 
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more prolonged exercise than that provided by Erkin V. Erkin VI was given 
before, after, and midway through bedrest periods. 
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15. DATA PROCESSING 
TILT STUDIES 
CODE SHEET TO MAGNETIC TAPE 
DATE MAGNETIC TAPE NO. 
IRCUMSTANCE 
OBSERVER 
STRIP CHART (OFFNER ETC.) RECORD MADE SIMULTANEOUSLY? 
YES NO 
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15.2 BICYCLE ERGOMETER STUDIES 
ERGOMETRY TEST INPUT DATA SHEET 
SUBJECT NAME DATE OF TEST 
IBM Number Barometric Pressure 
Age Room Temperature 
Sex Water Vapor Pressure 
Height (Actual) Humidity 
Weight (Actual) Duration of Test 
B.S.A. (Actual) Reference 
Weight (Theo.) Reason for Eval. 
B.S.A. (Theo.) Time of Test 
SAMPLE # 1 
Work Load 
Breaths/min. 
Heart Rate 
+E 
ATPS 
SAMPLE i+’ 2 
Work Load 
Breaths/min. 
Heart Rate 
, 
vE 
ATPS 
O2 
co 
2 
N 
2 
SAMPLE # 3 
Work Load 
Breaths/min. 
Heart Rate 
. 
vE 
ATPS 
O2 
co2 
SAMPLE # 4 
Work Load 
Breaths/min. 
Heart Rate 
vE 
ATPS 
0 
2 
co 
2 
N 
2 
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ERGOMETRY DATA CARDS 
Work Load 
Time of Test (Military Time) 
VEATPS 
0 Concentration 
2 
CO Concentration 
2 
N2 Concentration 
Barometric Pressure 
Room Temperature 
Partial Water Vapor Pressure 
Humidity 
Heart Rate 
Number of Breaths 
J I I I 
I I I I I 
I I I I I I I I 
I I I I I I I 
I I I I I I I 
I I I I I I 1 
I I I I I I 
I I I I I I 
I I I I I 1 
I I I I 
J I I I 
J I I I 
Card Column -- 
l- 3 
4- 7 
8- 14 
15- 20 
21 - 26 
2-7 - 32 
33 - 37 
38 - 42 
43 - 47 
48 - 50 
51 - 53 
54 - 56 
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Appendix 15.2.3 
IDENTIFICATION CARD NUMBER 1 
Column 
Name IIIIIIIIIIIIJ 
Date 
Age 
Sex 
Hospital Number 
Height 
Weight 
Body Surface Area 
Theoretical Weight 
Theoretical Body Surface Area 
Reference 
Reason 
Number of Phases 
IIlIllJ 
I IJ 
II 
J I I I I 1 
J I I I I 1 
L 1 I I I 
J I I 1 I 1 
J I I I I 
J I I I l I I 
1 I I I I I I 
1 I I 
Card 
1 
13 
19 
21 
22 
28 
33 
38 
42 
47 
51 
57 
63 
12 
18 
20 
27 
32 
37 
41 
46 
50 
56 
62 
64 
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Appendix 15.2.4 
PHASE CARD 
Card Column 
Beginning of Tests (Military Time) Jll Jl - 4 
Number of Ergometry Samples J 115 - 6 
Number of Ventilation Samples 1 I 17 - 8 
Number of BMR Samples 1 I 1 9 - 10 
Position - Phase Code 1 1 111 - 12 
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Appendix 15.2.5 
CODE SHEET FOR BICYCLE ERGOMETRY ANALOG DATA 
ON MAGNETIC TAPE 
MAGNETIC TAPE NUMBER 
MEASUREMENTS 
1 AIL 1 EECO CODE EXPERIMENTAL 
CODE SUBJECT TIME OF DAY HR.jMIN. SEC. CIRCUMSTANCE 
I I 
OBSERVER 
STRIP CHART (OFFNER, ETC.) RECORD MADE SIMULTANEOUSLY? 
YES NO 
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II - 
Appendix 15.2.4 
PHASE CARD 
Card Column 
Beginning of Tests (Military Time) Jll 11 - 4 
Number of Ergometry Samples 11 15 - 6 
Number of Ventilation Samples 11 17 - 8 
Number of BMR Samples j I 1 9 - 10 
Position - Phase Code 1 1 (11 - 12 
161 
w _._ ._ . 
Appendix 15.2.5 
CODE SHEET FOR BICYCLE ERGOMETRY ANALOG DATA 
ON MAGNETIC TAPE 
DATE MAGNETIC TAPE NUMBER 
MEASUREMENTS 
AIL ’ EECO CODE 
CODE SUBJECT TIME OF DAY HR.(MIN. 
I 
I 
I I I I I 
OBSERVER 
EXPERIMENTAL 1 CIRCUMSTANCE 
STRIP CHART (OFFNER, ETC.) RECORD MADE SIMULTANEOUSLY? 
YES NO 
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15.2.6 
ANALOG TAPE DESCRIPTION FORM 
DATE 
WBMITTE 
RECORDING SPEED CFU RECORDING HEAD 
TAPE 
TRACK 
01 
I 1 
FUNCTION RECORDED MEASUREMENT CODE 
03 
04 
05 
06 
1 08 I 
09 
10 
11 
I- 12 
13 
14 
15 
16 
SlDE 
ITRACKS 
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Appendix 15.2.7 
MICROSADIC REQUEST FORM 
I -S~~BH~TTTFK~'X~~T~E~RG .i -------t--- --- 
- - ~ROPER.iF~aF;-----' .-_. 
1-- ---- ----_--. .__ -- 
I 
I 
-?i6 OF FILES I START D@XODE --._.- I 1 
I 1-m 
-t.ING RM SCAS 
--7- 
.IIl 2 5 
cm 
--_ 
S 
i 1 I Il!liri-r 
rhg’ TqL RA,r ’ i2&------- 
1 TAPE TRACK1 : Cw---- -_.- 1 
I 02 
Iii ~---I---------- 
l 02 I I 02 --L -- 
i 0s I 10 ! I 
I 04 11 I 
05 12 -- ! -- 
06 I 12 i 
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DATA DCICRIPTION FORM 
Dlg11al Tape Label 
.-.- 
Daw Rvcorded __.- 
_ Subjecl 
1 1 , 1 1 ITmNo.1 
Central clfic 
B&y Plur Te PIUY MeaaIremeIm ._ I II 
1 I I I I I I I I I I I I 1 I I I I I I I 1 I I 
C.0.F , 
1 
IllllrllIlIlllUIllllll I I I I I I 1 
0. F. I 
I I I 
I 
Appendix 15.3 
ERKIN STUDIES: 
‘CODE SHEET EXERCISE ANALOG DATA 
ON MAGNETIC TAPE 
DATE MAGNETIC TAPE NUMBER 
MEASUREMENTS 
OBSERVER 
STRIP CHART (OFFNER, etc.) RECORD MADE SIMULTANEOUSLY? 
YES NO 
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